{
    "testId": 396302591,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 108,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 4,
    "questionModeName": "CUSTOM",
    "testName": "",
    "totalQuestionCorrect": 20,
    "correctToIncorrect": 0,
    "incorrectToCorrect": 2,
    "incorrectToIncorrect": 0,
    "timeInSeconds": 1682,
    "averageTimeSpentInSeconds": 132,
    "otherAverageTimeSpentInSeconds": 67,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 35,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "4",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 4223,
            "questionIndex": 4223,
            "questionText": "<p>A 5-hour-old boy is evaluated in the nursery for minimal right arm movement.&nbsp; He was born at 39 weeks gestation to a 37-year-old multigravida via vaginal delivery complicated by difficulty extracting the shoulders.&nbsp; Review of medical records reveals a maternal history of hypertension and recreational marijuana use.&nbsp; The mother missed most of her prenatal appointments.&nbsp; The patient&#39;s birth weight is 4.5 kg (9 lb 14 oz).&nbsp; Vital signs are normal.&nbsp; Examination shows a plethoric infant with crepitus and irregularity over the right clavicle.&nbsp; Moro reflex is absent on the right extremity.&nbsp; Bilateral biceps and grasp reflexes are intact and symmetric.&nbsp; Which of the following risk factors predisposed the infant to this complication?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"5247\" src=\"https://www.uworld.com/media/L16318.png\" ></p><p>This neonate&#39;s birth weight is consistent with&nbsp;macrosomia (fetal weight &#8805;4 kg [8 lb 13 oz]), and his physical examination findings reflect complications of shoulder dystocia. &nbsp;Fetal hyperglycemia (eg, due to untreated maternal diabetes mellitus) is the most common underlying risk factor.</p><p>Mild maternal insulin resistance is a physiologic process of pregnancy that facilitates the diffusion of glucose across the placenta for fetal growth.&nbsp; However, <strong>excessive maternal hyperglycemia</strong> (ie, gestational or prepregnancy diabetes mellitus) results in <strong>fetal hyperglycemia</strong>, which increases fetal pancreatic insulin secretion, causing fetal hyperinsulinemia.</p><p>Excessive production of fetal insulin, an anabolic hormone, leads to macrosomia with disproportionate growth and fat accumulation over the shoulders and abdomen.&nbsp; As a result, the shoulders can become impacted in the maternal pelvis, resulting in <strong>shoulder dystocia</strong>, an obstetric emergency.&nbsp; Potential complications of shoulder dystocia include <strong>clavicle fracture, brachial nerve palsy</strong>, perinatal asphyxia, and hypoxic encephalopathy.&nbsp; Maternal hyperglycemia can also lead to neonatal polycythemia and plethora as well as postnatal hypoglycemia.</p><p>Fetal hyperglycemia and hyperinsulinemia likely contributed to this patient&#39;s macrosomia, plethora, and shoulder dystocia with resultant clavicle fracture (eg, crepitus, asymmetric Moro reflex).</p><p><strong>(Choices A, B, D, and E)</strong>&nbsp; Congenital infections; fetal aneuploidy; and maternal hypertension and substance abuse are all associated with fetal growth restriction and small-for-gestational-age infants (eg, birth weight &lt;10th percentile).&nbsp; Fetal growth restriction occurs due to the compromise of placental function and a decreased ability to transport oxygen and other nutrients from mother to fetus.&nbsp; Decreased placental oxygen transfer can lead to fetal hypoxemia, in which the fetus attempts to maintain oxygenation by suppressing growth and metabolism.&nbsp; This infant has macrosomia rather than growth restriction.</p><p><strong>(Choice F)</strong>&nbsp; In addition to fetal growth restriction, maternal tobacco use can cause irritability and hypertonicity in newborns, neither of which are seen in this macrosomic patient.</p><p><strong>Educational objective:</strong><br>Excessive maternal hyperglycemia causes fetal hyperglycemia and hyperinsulinemia.&nbsp; Neonates may be macrosomic, increasing the risk of shoulder dystocia and its complications (eg, brachial nerve palsy, clavicle fracture).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 13253,
            "topic": "Infant of diabetic mother",
            "titleId": 13253,
            "title": "Infant of diabetic mother",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Congenital infection",
                    "choiceNumber": 1,
                    "correctTaken": 147,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal aneuploidy",
                    "choiceNumber": 2,
                    "correctTaken": 133,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal hyperglycemia",
                    "choiceNumber": 3,
                    "correctTaken": 13704,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal hypertension",
                    "choiceNumber": 4,
                    "correctTaken": 1767,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal marijuana abuse",
                    "choiceNumber": 5,
                    "correctTaken": 444,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal tobacco use",
                    "choiceNumber": 6,
                    "correctTaken": 221,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26045324",
                    "mediaDataId": 0,
                    "title": "Gestational diabetes mellitus and macrosomia: a literature review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26045324",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24020942",
                    "mediaDataId": 0,
                    "title": "Pregnancy week at delivery and the risk of shoulder dystocia: a population study of 2,014,956 deliveries.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24020942",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 256,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 16417,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 83,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 2563,
            "questionIndex": 2563,
            "questionText": "<p>A 26-year-old primigravid woman at 20 weeks gestation comes to the emergency department due to joint pain and swelling in her hands and feet over the past day.&nbsp; The patient reports good fetal movement and has no abdominal pain, bleeding, leakage of fluid, headaches, or visual changes.&nbsp; She has a history of systemic lupus erythematosus that was managed with hydroxychloroquine, which the patient stopped taking prior to conception.&nbsp; Blood pressure is 150/95 mm Hg; 5 minutes later, following rest in the lateral recumbent position, it is 140/95 mm Hg.&nbsp; Fetal heart rate by Doppler ultrasound is 145/min.&nbsp; Physical examination shows bilateral 2+ pitting edema of the legs and a red macular eruption on the cheeks.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>Hemoglobin</td><td>10.2 g/dL</td></tr><tr><td>Platelets</td><td>120,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Urinalysis</td><td>2+ protein, RBC casts</td></tr><tr><td>Urine protein (24 hour)</td><td>1.5 g</td></tr><tr><td>Blood urea nitrogen</td><td>28 mg/dL</td></tr><tr><td>Serum creatinine</td><td>2.1 mg/dL</td></tr><tr><td>Lactate dehydrogenase</td><td>62 U/L</td></tr></tbody></table><p>Serum electrolytes, liver function tests, and coagulation studies are within normal limits.&nbsp; Which of the following is the most likely diagnosis for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31514\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>SLE nephritis in pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical Presentation</strong></p></td><td><ul><li>Edema</li><li>Malar rash</li><li>Arthritis</li><li>Hematuria</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>Nephritic range proteinuria</li><li>Urinalysis with RBC &amp; WBC casts</li><li>&#8595; Complement levels</li><li>&#8593; ANA titers</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Renal biopsy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Obstetric complications</strong></p></td><td><ul><li>Preterm birth</li><li>Cesarean delivery</li><li>Preeclampsia</li><li>Fetal growth restriction</li><li>Fetal demise</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ANA</strong> = antinuclear antibodies; <strong>RBC</strong> = red blood cells; <strong>SLE</strong> =&nbsp;systemic lupus erythematosus; <strong>WBC</strong> = white blood cells.</p></td></tr></tbody></table></div><p>This patient at 20 weeks gestation has <strong>edema</strong>, joint pain, a malar rash, <strong>hypertension</strong>, and urinalysis with proteinuria and <strong>red blood casts</strong>, all of which are consistent with a <strong>systemic lupus erythematosus (SLE) flare</strong> complicated by <strong>nephritis</strong>.&nbsp; Pregnancy and the postpartum period are associated with an increased risk for SLE flares, particularly in patients with a history of lupus nephritis.&nbsp; Other risk factors include <strong>discontinuation of hydroxychloroquine</strong> and active disease prior to conception.&nbsp; SLE is associated with an increased risk for obstetrical complications, including preeclampsia, preterm birth, cesarean delivery, fetal growth restriction, and fetal demise.</p><p>In patients known to have SLE prior to conception, the appearance of proteinuria during pregnancy may represent an SLE flare complicated by nephritis, preeclampsia, or both.&nbsp; Distinguishing between lupus nephritis and preeclampsia can be difficult as both present with edema, hypertension, and proteinuria <strong>(Choice D)</strong>.&nbsp; However, lupus nephritis presents with the associated signs and symptoms of SLE (eg, joint pain, malar rash) and the presence of red blood cell casts on urinalysis.&nbsp; Lupus nephritis can be further distinguished from preeclampsia by decreased complement levels and increasing antinuclear antibody titers.</p><p><strong>(Choice A)</strong>&nbsp; Gestational hypertension is hypertension at <u>&gt;</u>20 weeks gestation with no evidence of proteinuria or end-organ damage.&nbsp; This patient has both proteinuria and end-organ damage.</p><p><strong>(Choice B)</strong>&nbsp; HELLP syndrome (hemolysis, elevated liver enzymes, low platelet count) presents with hypertension, thrombocytopenia, and proteinuria.&nbsp; However, it also presents with elevated liver enzymes and hemolysis, neither of which are seen in this patient.</p><p><strong>(Choice C)</strong>&nbsp; Hemolytic uremic syndrome presents with acute renal injury, thrombocytopenia, and microangiopathic hemolytic anemia most frequently due to infection with Shiga toxin-producing <em>Escherichia coli</em>.&nbsp; This patient has a normal lactate dehydrogenase and no other evidence of hemolysis, making this diagnosis less likely.</p><p><strong>Educational objective:</strong><br>Hypertension during pregnancy in a patient with edema, joint pain, a malar rash, and urinalysis with proteinuria and red blood cell casts is most likely due to a systemic lupus erythematosus flare complicated by nephritis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4622,
            "topic": "Glomerular disorders",
            "titleId": 4622,
            "title": "Glomerular disorders",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Gestational hypertension",
                    "choiceNumber": 1,
                    "correctTaken": 287,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "HELLP syndrome",
                    "choiceNumber": 2,
                    "correctTaken": 544,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemolytic uremic syndrome",
                    "choiceNumber": 3,
                    "correctTaken": 372,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preeclampsia",
                    "choiceNumber": 4,
                    "correctTaken": 4691,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Systemic lupus erythematosus flare",
                    "choiceNumber": 5,
                    "correctTaken": 10765,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27377453",
                    "mediaDataId": 0,
                    "title": "A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27377453",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 61,
            "othersAvgTimeSpent": 73,
            "notes": null,
            "peopleTaken": 16659,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 10838,
            "questionIndex": 11969,
            "questionText": "<p>A 39-year-old woman, gravida 3 para 2, comes to the office at 20 weeks gestation for prenatal care and follow-up of a prenatal ultrasound.&nbsp; The patient has had no pelvic pain, leakage of fluid, or vaginal bleeding.&nbsp; Fetal movement has been normal.&nbsp; Prior pregnancies were uncomplicated and delivered vaginally at term.&nbsp; This pregnancy was conceived via in vitro fertilization with normal preimplantation genetic testing.&nbsp; Blood pressure is 110/60 mm Hg and pulse is 78/min.&nbsp; BMI is 32 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Ultrasound performed earlier today showed a single fetus in the breech presentation, a placenta covering the internal cervical os, and a cervical length of 4.2 cm.&nbsp; The anatomical survey is normal, and estimated fetal weight is at the 50th percentile.&nbsp; The ultrasound findings are explained to the patient.&nbsp; Based on these findings, which of the following is the best next step in management of this patient at this time?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33314\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Placenta previa </strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors </strong></p></td><td><ul><li>Prior placenta previa</li><li>Prior cesarean delivery</li><li>Multiple gestation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features </strong></p></td><td><ul><li>Painless vaginal bleeding at &gt;20 weeks gestation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis </strong></p></td><td><ul><li>Transabdominal followed by transvaginal sonography</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management </strong></p></td><td><ul><li>No intercourse</li><li>No digital cervical examination</li><li>Inpatient admission for bleeding episodes</li></ul></td></tr></tbody></table></div><p><a href=\"4268\">Placenta previa</a> is usually diagnosed during routine prenatal ultrasound at 18-20 weeks gestation with <strong>placental tissue covering the cervix</strong>.&nbsp; Most patients are asymptomatic but have a significant risk of severe <strong>painless antepartum hemorrhage</strong> due to partial placental detachment with cervical manipulation or dilation.</p><p>The <strong>majority</strong> (~90%) of cases <strong>resolve spontaneously</strong> due to lower uterine segment lengthening and/or placental growth toward the fundus; therefore, initial management is with <strong>routine obstetric care</strong>.&nbsp; <strong>Pelvic rest</strong> and abstinence from intercourse (due to potential cervical contact) are recommended, and clinicians should refrain from digital cervical examination.&nbsp; Repeat ultrasound is performed in the third trimester (ie, &#8805;28 weeks gestation), and patients with previa resolution can continue routine care without pelvic rest restrictions.&nbsp; Asymptomatic patients (ie, no vaginal bleeding) with persistent previa undergo scheduled cesarean delivery at 36-37 weeks gestation.</p><p><strong>(Choice A)</strong>&nbsp; Cerclage treats cervical insufficiency by reinforcing the cervix with suture or synthetic tape; candidates include patients with a history of second-trimester deliveries or a short (&#8804;2.5 cm) cervix.&nbsp; It is not indicated in this patient with 2 prior term deliveries and a normal cervix, and it has no role in the management of placenta previa.</p><p><strong>(Choice B)</strong>&nbsp; Complete bed rest is associated with an increased risk of venous thromboembolism and loss of bone density.&nbsp; In addition, it has not been proven to be beneficial in obstetric management and therefore is not recommended.</p><p><strong>(Choices C and E)</strong>&nbsp; Progesterone supplementation may reduce the risk of preterm birth in patients with prior preterm birth (by intramuscular hydroxyprogesterone) or those with an incidental short cervix (with vaginal progesterone).&nbsp; This patient&#39;s prior pregnancies were delivered at term, and her cervical length is normal (&gt;2.5 cm).</p><p><strong>(Choice F)</strong>&nbsp; Doppler ultrasound of the umbilical artery is performed during surveillance of fetal growth restriction (estimated fetal weight &lt;10th percentile); this patient&#39;s fetal growth is normal (50th percentile).</p><p><strong>Educational objective:</strong><br>Placenta previa is diagnosed on prenatal ultrasound, when the placental tissue is seen covering the cervix.&nbsp; Cervical manipulation may cause severe painless antepartum hemorrhage; therefore, pelvic rest (ie, no digital cervical examination or intercourse) is recommended.&nbsp; Asymptomatic patients (ie, no vaginal bleeding) undergo routine obstetric care and third-trimester ultrasound to evaluate for previa resolution.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14133,
            "topic": "Antepartum bleeding",
            "titleId": 14133,
            "title": "Antepartum bleeding",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cerclage placement",
                    "choiceNumber": 1,
                    "correctTaken": 687,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Imposition of complete bed rest",
                    "choiceNumber": 2,
                    "correctTaken": 979,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intramuscular hydroxyprogesterone",
                    "choiceNumber": 3,
                    "correctTaken": 192,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Routine obstetric care",
                    "choiceNumber": 4,
                    "correctTaken": 9779,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vaginal progesterone",
                    "choiceNumber": 5,
                    "correctTaken": 587,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Weekly Doppler ultrasound",
                    "choiceNumber": 6,
                    "correctTaken": 2136,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26244528",
                    "mediaDataId": 0,
                    "title": "Abnormal placentation: placenta previa, vasa previa, and placenta accreta.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26244528",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 121,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 14360,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 3893,
            "questionIndex": 3893,
            "questionText": "<p>A 35-year-old woman, gravida 4 para 1 aborta 2, comes to the office for her first prenatal visit.&nbsp; Her last menstrual period was 7 weeks ago, and she is concerned about a recent episode of vaginal bleeding and cramping.&nbsp; A home pregnancy test was positive a few days after the patient&#39;s missed menstrual period.&nbsp; Around that time, she had nausea that has since subsided.&nbsp; She has had 1 prior full-term delivery followed by 2 early first-trimester losses requiring dilation and curettage procedures.&nbsp; Six months ago, she had an isolated episode of sudden right arm weakness and slurred speech, which resolved spontaneously 2 hours later.&nbsp; The patient takes a daily prenatal vitamin but no other medications.&nbsp; BMI is 34 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Blood pressure is 130/80 mm Hg.&nbsp; Pelvic examination shows a closed cervix; no vaginal bleeding; and a slightly enlarged, irregularly shaped uterus.&nbsp; Ultrasound reveals an empty uterus with a single subserosal fibroid that is 2 cm in diameter.&nbsp; &#946;-hCG is 23 IU/L.&nbsp; Which of the following maternal factors is the most likely cause of this patient&#39;s miscarriage?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35373\"><table class=\"table-default-style\" style=\"width:468px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Diagnostic criteria for antiphospholipid-antibody syndrome</strong></p><p align=\"center\"><strong>(1 clinical &amp; 1 laboratory criterion must be met)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical</strong></p></td><td><p><strong>Vascular thrombosis</strong></p><ul><li>Arterial or venous</li></ul><p><strong>Pregnancy morbidity</strong></p><ul><li>&ge;3 consecutive, unexplained fetal losses before 10th week</li><li>&ge;1 unexplained fetal losses after 10th week</li><li>&ge;1 premature births of normal neonates before 34th week due to preeclampsia, eclampsia, or placental insufficiency</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory</strong></p></td><td><ul><li>Lupus anticoagulant</li><li>Anticardiolipin antibody</li><li>Anti&ndash;beta-2 glycoprotein antibody I</li></ul></td></tr></tbody></table></div><p>This patient has now had 3 consecutive spontaneous abortions consistent with <strong>recurrent pregnancy loss</strong> (RPL).&nbsp; There are multiple etiologies for RPL, including structural (eg, uterine anomaly), genetic (eg, aneuploidy), and endocrine (eg, diabetes mellitus) causes.&nbsp; However, in this young woman who has also had a prior episode of sudden weakness and slurred speech (suggesting a <strong>transient ischemic attack</strong>), the most likely etiology of her RPL is <strong>antiphospholipid antibody syndrome</strong> (APS).</p><p>APS is an autoimmune disorder caused by antiphospholipid antibodies (eg, lupus anticoagulant, anticardiolipin antibody) that create a <strong>hypercoagulable state</strong> leading to <strong>venous and/or arterial thrombosis</strong> (eg, transient ischemic attack).&nbsp; During pregnancy, APS can cause placental vessel thrombosis, which may result in RPL (as in this patient) or in other pregnancy complications (eg, preeclampsia, placental insufficiency).</p><p>Due to the high risk of venous and/or arterial thrombosis, patients with APS require <strong>chronic anticoagulation</strong>.&nbsp; Nonpregnant patients are anticoagulated with warfarin; pregnant patients receive low molecular weight heparin.</p><p><strong>(Choice A)</strong>&nbsp; Multiple sclerosis causes multiple, focal, demyelinating lesions of the CNS and may present with arm weakness and slurred speech.&nbsp; However, multiple sclerosis is not a cause of RPL, making this diagnosis less likely.</p><p><strong>(Choice B)</strong>&nbsp; Submucosal and intracavitary uterine fibroids may cause RPL due to interference with implantation.&nbsp; <a href=\"1140\">Subserosal fibroids</a> are located outside the uterine cavity and therefore typically do not interfere with implantation or cause miscarriage.</p><p><strong>(Choice D)</strong>&nbsp; Patients with insulin resistance (eg, type 2 diabetes mellitus) are at increased risk of miscarriage, particularly those with high glucose levels (due to congenital anomalies and/or placental hypoperfusion).&nbsp; Patients with pregnancy loss due to insulin resistance typically have known poorly controlled diabetes mellitus, in contrast to this patient with no known medical conditions.</p><p><strong>(Choice E)</strong>&nbsp; A subclinical uterine infection (eg, chronic endometritis, pelvic inflammatory disease) can cause infertility by interfering with implantation.&nbsp; It is not associated with RPL or arm weakness and slurred speech.</p><p><strong>Educational objective:</strong><br>Patients with recurrent pregnancy loss plus an unprovoked venous and/or arterial thrombosis (eg, transient ischemic attack) may have antiphospholipid antibody syndrome, an autoimmune disorder that causes a hypercoagulable state.&nbsp; Management is with chronic anticoagulation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 15843,
            "topic": "Antiphospholipid syndrome",
            "titleId": 15843,
            "title": "Antiphospholipid syndrome",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Demyelinating lesions",
                    "choiceNumber": 1,
                    "correctTaken": 548,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fibroid uterus",
                    "choiceNumber": 2,
                    "correctTaken": 3108,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypercoagulable state",
                    "choiceNumber": 3,
                    "correctTaken": 12684,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Insulin resistance",
                    "choiceNumber": 4,
                    "correctTaken": 210,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Subclinical uterine infection",
                    "choiceNumber": 5,
                    "correctTaken": 149,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26637701",
                    "mediaDataId": 0,
                    "title": "The antiphospholipid syndrome: still an enigma.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26637701",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 83,
            "othersAvgTimeSpent": 71,
            "notes": null,
            "peopleTaken": 16700,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 17123,
            "questionIndex": 18574,
            "questionText": "<p>A 22-year-old woman with type 1 diabetes mellitus is evaluated in the labor and delivery department due to drowsiness.&nbsp; The patient is somnolent but rouses to sternal rub.&nbsp; An hour ago, the patient underwent a cesarean delivery after a failed induction of labor for preeclampsia with severe features.&nbsp; Her delivery was complicated by postpartum hemorrhage with an estimated blood loss of 2,000 mL due to a torn uterine artery.&nbsp; She is currently receiving a magnesium sulfate infusion and a basal-bolus insulin regimen.&nbsp; Temperature is 99.7 F (37.6 C), blood pressure is 148/96 mm Hg, pulse is 70, and respirations are 10/min.&nbsp; The lungs are clear to auscultation bilaterally.&nbsp; Abdominal examination shows a firm uterus with normal tenderness to palpation.&nbsp; The Pfannenstiel incision is intact and has minimal bleeding.&nbsp; The patellar reflexes are absent bilaterally.&nbsp; There is minimal, dark urine in the Foley catheter.&nbsp; Fingerstick blood glucose level is 240 mg/dL.&nbsp; Which of the following is the most likely cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t42295\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Magnesium toxicity</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Mild: nausea, flushing, headache, hyporeflexia</li><li>Moderate: areflexia, hypocalcemia, somnolence</li><li>Severe: respiratory paralysis, cardiac arrest</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Stop magnesium therapy</li><li>Give IV&nbsp;calcium gluconate bolus</li></ul></td></tr></tbody></table></div><p>Patients with preeclampsia with severe features are administered magnesium sulfate to prevent eclamptic seizures because magnesium acts as a calcium channel blocker on the CNS, thereby raising the seizure threshold.&nbsp; Therapeutic serum magnesium levels (ie, 4.8-8.4 mEq/L), which are 2-4 times higher than normal concentrations, are required to prevent eclampsia.&nbsp; Normally, this therapeutic range is maintained between the balance of magnesium sulfate infusion and renal excretion of magnesium.&nbsp; However, in patients with abnormal renal function&mdash;as evidenced by either an elevated creatinine level or decreased urine output (as in this patient with minimal, dark urine)&mdash;magnesium can be retained and increase to toxic levels.</p><p>High levels of magnesium inhibit presynaptic acetylcholine release, thereby causing neuromuscular inhibition.&nbsp; Therefore, the first sign of <strong>magnesium sulfate toxicity</strong> is often hyporeflexia.&nbsp; As magnesium levels increase, patients can develop <strong>areflexia</strong> (eg, loss of patellar reflexes) and <strong>respiratory depression</strong> (eg, <strong>drowsiness</strong>, respirations &#8804;12/min).&nbsp; If untreated, patients are at risk for respiratory paralysis and cardiac arrest.&nbsp; Treatment is immediate cessation of magnesium sulfate and administration of <strong>calcium gluconate</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Acute blood loss anemia (eg, postpartum hemorrhage) may present with drowsiness due to hypoxia and decreased urine output due to hypovolemia.&nbsp; However, these patients typically have tachycardia, tachypnea, and hypotension, which are not seen in this patient.&nbsp; In addition, anemia does not cause absent patellar reflexes.</p><p><strong>(Choice B)</strong>&nbsp; Amniotic fluid embolism (AFE) is an obstetric emergency that causes sudden cardiopulmonary collapse and possible disseminated intravascular coagulopathy.&nbsp; In contrast to this patient, those with an AFE have an abnormal lung examination (eg, bilateral crackles) and tachypnea, rather than respiratory depression.&nbsp; In addition, there is no associated areflexia.</p><p><strong>(Choice C)</strong>&nbsp; Diabetic ketoacidosis (DKA) can cause neurologic changes (eg, somnolence), but it typically occurs when hyperglycemia is severe (eg, &gt;350 mg/dL).&nbsp; In contrast to this patient, DKA usually causes tachypnea and increased urine output.</p><p><strong>(Choice D)</strong>&nbsp; Patients with preeclampsia are at increased risk for eclamptic seizure, and an eclamptic postictal state can present with drowsiness.&nbsp; However, affected patients typically have hyperreflexia (eg, clonus) rather than areflexia.</p><p><strong>Educational objective:</strong><br>Patients with magnesium sulfate toxicity typically have absent patellar reflexes and respiratory depression; toxicity can progress to respiratory paralysis and cardiac arrest.&nbsp; Treatment is cessation of magnesium sulfate and administration of calcium gluconate.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4219,
            "topic": "Preeclampsia",
            "titleId": 4219,
            "title": "Preeclampsia",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute blood loss anemia",
                    "choiceNumber": 1,
                    "correctTaken": 300,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Amniotic fluid embolism",
                    "choiceNumber": 2,
                    "correctTaken": 134,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diabetic ketoacidosis",
                    "choiceNumber": 3,
                    "correctTaken": 319,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Eclamptic postictal state",
                    "choiceNumber": 4,
                    "correctTaken": 263,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Magnesium sulfate toxicity",
                    "choiceNumber": 5,
                    "correctTaken": 4002,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26695587",
                    "mediaDataId": 0,
                    "title": "ACOG committee opinion no 652: magnesium sulfate use in obstetrics.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26695587",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23383864",
                    "mediaDataId": 0,
                    "title": "An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23383864",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 107,
            "othersAvgTimeSpent": 88,
            "notes": null,
            "peopleTaken": 5018,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 80,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 17562,
            "questionIndex": 19019,
            "questionText": "<p>A 29-year-old woman, gravida 1 para 1, is evaluated in the emergency department for a headache.&nbsp; Three days ago, she had an uncomplicated vaginal delivery with neuraxial anesthesia.&nbsp; This morning, the patient developed an occipital headache that has not improved with acetaminophen.&nbsp; The headache has become progressively worse, and the patient cannot sit without becoming nauseated and vomiting.&nbsp; The patient has no chronic medical conditions and does not use tobacco, alcohol, or illicit drugs.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 162/96 mm Hg, pulse is 98/min, and respirations are 18/min.&nbsp; On examination, heart sounds are normal with no rubs or murmurs, and the lungs are clear to auscultation.&nbsp; Cranial nerves are intact and deep tendon reflexes are 3+.&nbsp; There is 5/5 strength in the right lower extremity and 3/5 strength in the left.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t40818\"><table class=\"table-default-style table-header-footer-style\" style=\"width:614px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Preeclampsia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Nulliparity</li><li>Obesity</li><li>Preexisting medical condition (eg, SLE, chronic hypertension)</li><li>Multiple gestation</li><li>Advanced maternal age</li></ul></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>New-onset hypertension* (SBP &ge;140 or DBP &ge;90&nbsp;mm&nbsp;Hg)<br />at &ge;20&nbsp;weeks</li></ul><p style=\"margin-left:.25in;\">&nbsp; &nbsp; &nbsp;AND</p><ul><li>Proteinuria OR signs/symptoms of other end-organ damage</li></ul></td></tr><tr><td><p align=\"center\"><strong>Severe features</strong></p></td><td><ul><li>Severe-range hypertension (SBP &ge;160 or DBP &ge;110&nbsp;mm&nbsp;Hg)</li><li>Platelets &lt;100,000/mm<sup>3</sup></li><li>Creatinine &gt;1.1 mg/dL or 2x normal</li><li>Elevated transaminases &gt;2x upper limit of normal</li><li>Pulmonary edema</li><li>Vision&nbsp;or cerebral symptoms (eg, headache)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>&lt;37 weeks &amp; no severe features: expectant</li><li>&ge;37 weeks (or &ge;34&nbsp;weeks with severe features): delivery</li><li>Severe-range blood pressure: IV labetalol, IV hydralazine,<br />PO nifedipine</li><li>Seizure prophylaxis: magnesium sulfate</li></ul></td></tr><tr><td colspan=\"2\"><p>*On 2 measurements &ge;4 hr apart.</p><p><strong>DBP</strong>&nbsp;=&nbsp;diastolic blood pressure; <strong>IV</strong>&nbsp;=&nbsp;intravenous; <strong>PO</strong>&nbsp;=&nbsp;by mouth; <strong>SBP</strong>&nbsp;=&nbsp;systolic blood pressure; <strong>SLE</strong>&nbsp;=&nbsp;systemic lupus erythematosus.</p></td></tr></tbody></table></div><p>This <strong>postpartum</strong> patient with <strong>worsening headache</strong> and <strong>severe hypertension</strong> (eg, systolic &#8805;160 or diastolic &#8805;110 mm Hg) has <strong>preeclampsia with severe features</strong>, which can present up to 6 weeks after delivery.&nbsp; The most common presenting symptom is a severe headache in the bilateral occipital or frontal regions that does not improve with acetaminophen or nonsteroidal anti-inflammatory drugs.</p><p>Patients with preeclampsia are at increased risk of <strong>hemorrhagic and ischemic stroke</strong> due to acute elevations in cerebral perfusion pressure and vessel rupture (hemorrhagic), as well as preeclampsia-mediated vascular endothelial damage and microthrombi formation (ischemic).&nbsp; To decrease this risk, preeclamptic patients with severe-range blood pressures require aggressive antihypertensive therapy (eg, labetalol, nifedipine) and magnesium sulfate, which helps prevent eclamptic seizures that can worsen stroke symptoms.</p><p>Most preeclamptic patients do not require imaging; however, in those with <strong>focal neurologic deficits</strong>, such as this patient with asymmetric motor deficits (strength right &gt; left), <strong>CT scan of the head</strong> should be performed to evaluate for possible stroke and help guide management.</p><p><strong>(Choices A and E)</strong>&nbsp; Oxygen administration is used to alleviate cluster headaches, which typically present with a short-lived, unilateral, orbital headache with autonomic symptoms (eg, ptosis, lacrimation).&nbsp; Triptans (eg, sumatriptan) are used to treat migraines, which can present as occipital headaches with nausea, vomiting, and occasionally motor aura (eg, hemiplegic migraine).&nbsp; However, CT scan should be performed in this patient prior to attempting symptomatic therapy in order to exclude life-threatening causes of neurologic deficit.</p><p><strong>(Choice C)</strong>&nbsp; An epidural blood patch is used to treat postdural puncture headaches, which can occur after neuraxial anesthesia and may present as an occipital headache that worsens with sitting or standing due to cerebrospinal fluid (CSF) leakage.&nbsp; However, this type of headache is not associated with hypertension or focal neurologic deficits.</p><p><strong>(Choice D)</strong>&nbsp; Lumbar puncture can evaluate for CSF infection (eg, meningitis, encephalitis), which may present with headache after neuraxial anesthesia.&nbsp; This patient is afebrile, making this diagnosis less likely.&nbsp; In addition, lumbar puncture is usually performed after CT scan to exclude a brain mass because there is a risk of herniation with mass effect.</p><p><strong>Educational objective:</strong><br>Preeclampsia can present up to 6 weeks postpartum with headache and hypertension.&nbsp; Patients with preeclampsia are at increased risk of stroke, and those with focal neurologic deficits should be evaluated with CT scan of the head.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4219,
            "topic": "Preeclampsia",
            "titleId": 4219,
            "title": "Preeclampsia",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "100% oxygen",
                    "choiceNumber": 1,
                    "correctTaken": 591,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "CT scan of the head",
                    "choiceNumber": 2,
                    "correctTaken": 10239,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Epidural blood patch",
                    "choiceNumber": 3,
                    "correctTaken": 5359,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lumbar puncture",
                    "choiceNumber": 4,
                    "correctTaken": 1202,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sumatriptan therapy",
                    "choiceNumber": 5,
                    "correctTaken": 418,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29438078",
                    "mediaDataId": 0,
                    "title": "Preeclampsia: association with posterior reversible encephalopathy syndrome and stroke.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29438078",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24431615",
                    "mediaDataId": 0,
                    "title": "Cerebrovascular complications in pregnancy and puerperium.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24431615",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 218,
            "othersAvgTimeSpent": 59,
            "notes": null,
            "peopleTaken": 17809,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 57,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 12697,
            "questionIndex": 13978,
            "questionText": "<p>A 23-year-old woman, gravida 1 para 1, is evaluated on the postpartum floor for fever.&nbsp; The patient awoke this morning with fever, chills, and increasing abdominal pain.&nbsp; She is passing flatus and has no nausea.&nbsp; Two days ago, the patient was in active labor, developed prolonged fetal bradycardia, and was rushed to the operating room for an emergency cesarean delivery under general anesthesia.&nbsp; The fetus was delivered with Apgar scores of 6 and 8 at 1 and 5 minutes, respectively.&nbsp; The patient was unable to void on the first postoperative day, so the Foley catheter was replaced and is continuing to drain.&nbsp; The patient developed a fever this morning, and now her temperature is 38.4 C (101.1 F).&nbsp; Bilateral breasts are engorged, tender, and have no erythema.&nbsp; The uterine fundus is nontender and palpable at the umbilicus.&nbsp; The skin overlying the incision is intact and has induration and erythema extending to the mons pubis.&nbsp; There are no palpable abdominal masses, rebound, or guarding.&nbsp; A Foley catheter is draining blood-tinged urine.&nbsp; Urinalysis shows trace blood, negative leukocyte esterase, and negative nitrites.&nbsp; Which of the following is the most likely underlying cause of this patient&#39;s presentation?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient with postpartum fever (&#8805;38 C more than 24 hours after delivery), wound induration, and incisional erythema most likely has <strong>cellulitis</strong>, a superficial <strong>surgical site infection</strong> due to <strong>incisional bacterial contamination</strong> during her cesarean delivery.&nbsp; Risk factors for wound infection include obesity and emergency surgery (eg, inadequate skin antisepsis or antibiotic prophylaxis).</p><p>Patients typically develop superficial <strong>surgical site infection</strong> within days to weeks after surgery.&nbsp; Typical signs include <strong>wound induration and erythema</strong>, which begins at the incision site at the level of the dermis but may also spread to surrounding subcutaneous tissue, resulting in edema, subcutaneous fluid accumulation, and increased peri-incisional pain.</p><p>Treatment of nonpurulent cellulitis is with first-generation cephalosporins (eg, cephalexin) because they cover common skin pathogens (eg, beta-hemolytic streptococci, methicillin-susceptible <em>Staphylococcus aureus</em> [MSSA]).</p><p><strong>(Choice B)</strong>&nbsp; This patient&#39;s hematuria and urinary retention are likely due to bladder and urethra trauma during labor and general anesthesia.&nbsp; Urinary retention is managed with Foley catheter replacement, which can cause catheter-introduced bacteriuria and cystitis.&nbsp; This patient&#39;s urinalysis is normal (eg, negative leukocyte esterase and nitrites), making this diagnosis unlikely.</p><p><strong>(Choice C)</strong>&nbsp; Septic pelvic thrombophlebitis can cause postpartum fever due to injury, thrombus, and hematogenous spread of infection to the pelvic veins (eg, ovarian veins).&nbsp; Patients are typically initially treated for suspected endometritis but have relapsing-remitting fevers and persistent abdominal pain despite antibiotics.&nbsp; Septic pelvic thrombophlebitis is not associated with incisional induration or erythema.</p><p><strong>(Choice D)</strong>&nbsp; Breast tenderness and engorgement can be due to normal postpartum milk letdown or signs of developing mastitis, which is caused by obstruction, inflammation, and infection of the breast ducts.&nbsp; However, patients with mastitis typically have high fevers, malaise, and unilateral breast erythema (not seen in this patient).</p><p><strong>(Choice E)</strong>&nbsp; Patients who undergo cesarean delivery are at risk for endometritis, a polymicrobial infection of the intrauterine cavity and common cause of postpartum fever.&nbsp; Patients with endometritis typically have uterine fundal tenderness, which is not seen in this patient.</p><p><strong>Educational objective:</strong><br>Superficial surgical site infection (ie, cellulitis) can occur after cesarean delivery and present with postpartum fever (&#8805;38 C more than 24 hours after delivery) as well as incisional induration and erythema.&nbsp; Risk factors include obesity and emergency surgery (eg, inadequate skin antisepsis or antibiotic prophylaxis).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23560,
            "topic": "Postoperative fever",
            "titleId": 23560,
            "title": "Postoperative fever",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bacterial contamination of the incision",
                    "choiceNumber": 1,
                    "correctTaken": 8091,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bladder infection from catheter-introduced bacteriuria",
                    "choiceNumber": 2,
                    "correctTaken": 2797,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Injury, thrombus, and infection of the pelvic veins",
                    "choiceNumber": 3,
                    "correctTaken": 3512,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obstruction, inflammation, and infection of the breast ducts",
                    "choiceNumber": 4,
                    "correctTaken": 255,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Polymicrobial infection of the uterine decidua",
                    "choiceNumber": 5,
                    "correctTaken": 2251,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28690864",
                    "mediaDataId": 0,
                    "title": "Surgical site infections after cesarean delivery: epidemiology, prevention and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28690864",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20846254",
                    "mediaDataId": 0,
                    "title": "Effects of postoperative analgesia on postpartum urinary retention in women undergoing cesarean delivery.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20846254",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 253,
            "othersAvgTimeSpent": 89,
            "notes": null,
            "peopleTaken": 16906,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 14144,
            "questionIndex": 15547,
            "questionText": "<p>A 26-year-old woman, gravida 2 para 1, at 35 weeks gestation comes to the labor and delivery department due to regular, painful contractions over the past 3 hours.&nbsp; The patient has had no prenatal care during this pregnancy.&nbsp; She has no chronic medical conditions, and her only surgery was a low transverse cesarean delivery 2 years ago.&nbsp; Her cervix on admission is 7 cm dilated and 100% effaced with the fetal head at +2 station.&nbsp; Fetal heart rate tracing on admission is category 1.&nbsp; Epidural analgesia is administered, and the patient has pain relief from the contractions.&nbsp; Rupture of membranes results in bright-red amniotic fluid.&nbsp; Blood pressure is 130/80 mm Hg and pulse is 112/min.&nbsp; Current fetal monitoring is as seen in the <a href=\"20466\">exhibit</a>.&nbsp; Which of the following is the most likely cause of this fetal heart rate tracing?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t44513\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Fetal heart rate tracing patterns</strong></p></td></tr><tr><td><p align=\"center\"><strong>Category I</strong></p></td><td><p>Requires all the following criteria:</p><ul><li>Baseline 110-160/min</li><li>Moderate variability (6-25/min)</li><li>No late/variable decelerations</li><li>&plusmn; Early decelerations</li><li>&plusmn; Accelerations</li></ul></td></tr><tr><td><p align=\"center\"><strong>Category II</strong></p></td><td><ul><li>Not category I or III (indeterminate pattern)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Category III</strong></p></td><td><p>&ge;1 of the following characteristics:</p><ul><li>Absent variability + recurrent late decelerations</li><li>Absent variability + recurrent variable decelerations</li><li>Absent variability + bradycardia</li><li>Sinusoidal pattern</li></ul></td></tr></tbody></table></div><p>Fetal heart rate (FHR) monitoring in labor assesses fetal oxygenation and metabolic status to prevent fetal morbidity and mortality.&nbsp; A category I FHR tracing (reassuring) has a low risk of fetal hypoxemia and acidemia and is managed expectantly.&nbsp; In contrast, a category III FHR tracing has an increased risk of fetal compromise and requires urgent intervention to prevent fetal injury and demise.</p><p>This patient has a <strong>sinusoidal fetal heart rate tracing</strong>, defined as a <a href=\"4570\">smooth, wave-like oscillation</a> (ie, rolling line), with fixed amplitude (5-15/min) and frequency (3-5 cycles/min).&nbsp; Sinusoidal tracings are a <strong>category III tracing</strong> and are considered ominous because they are associated with <strong>severe fetal anemia</strong>, suggested in this patient with likely fetal blood loss from ruptured <a href=\"1115\">vasa previa</a> (eg, bright-red amniotic fluid).&nbsp; Due to rapid <strong>fetal exsanguination and deterioration</strong>, this patient requires <strong>urgent cesarean delivery</strong>.</p><p><strong>(Choice B)</strong>&nbsp; Intraamniotic infection (chorioamnionitis) is usually associated with prolonged membrane rupture.&nbsp; FHR monitoring typically shows <a href=\"4569\">fetal tachycardia</a> (&gt;160/min) due to maternal fever and increased sympathetic drive.</p><p><strong>(Choices C and E)</strong>&nbsp; Oligohydramnios (amniotic fluid index &#8804;5 cm) may cause <a href=\"2412\">variable decelerations</a> due to umbilical cord compression.&nbsp; Variable decelerations occur because, as the uterus contracts, the umbilical cord is compressed, initially affecting the thin-walled umbilical vein and causing a transient reflex rise in the FHR.&nbsp; Continued cord compression eventually occludes the thick-walled umbilical artery, causing a rapid increase in blood pressure and subsequent abrupt drop in heart rate (ie, parasympathetic response).&nbsp; As the contraction releases, there is an equally rapid return to baseline.</p><p><strong>(Choice D)</strong>&nbsp; Preterm (&lt;37 week) gestation may be associated with an increased FHR baseline, reduced variability, and lower-amplitude accelerations.&nbsp; It does not cause sinusoidal rhythms.</p><p><strong>Educational objective:</strong><br>Sinusoidal fetal heart rate tracings are typically associated with severe fetal anemia.&nbsp; They are a category III tracing that reflects an increased risk of fetal compromise (eg, hypoxemia, acidemia) and requires urgent cesarean delivery.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 22374,
            "topic": "Fetal heart tracing",
            "titleId": 22374,
            "title": "Fetal heart tracing",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Fetal blood loss",
                    "choiceNumber": 1,
                    "correctTaken": 11683,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intraamniotic infection",
                    "choiceNumber": 2,
                    "correctTaken": 948,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oligohydramnios",
                    "choiceNumber": 3,
                    "correctTaken": 1024,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preterm gestation",
                    "choiceNumber": 4,
                    "correctTaken": 989,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Umbilical cord compression",
                    "choiceNumber": 5,
                    "correctTaken": 1973,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29341561",
                    "mediaDataId": 0,
                    "title": "Massive fetomaternal hemorrhage as a cause of severe fetal anemia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29341561",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28157275",
                    "mediaDataId": 0,
                    "title": "Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28157275",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19114268",
                    "mediaDataId": 0,
                    "title": "Antepartum high-frequency fetal heart rate sinusoidal rhythm: computerized detection and fetal anemia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19114268",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 110,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 16617,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 70,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 13179,
            "questionIndex": 14532,
            "questionText": "<p>A 27-year-old woman, gravida 3 para 2, at 14 weeks gestation comes to the office for an initial prenatal visit.&nbsp; The patient has had no vaginal bleeding, pelvic pain, or abnormal vaginal discharge.&nbsp; Her first 2 pregnancies ended with losses at 21 weeks gestation; both deliveries occurred after light vaginal spotting followed by a precipitous, nonpainful vaginal delivery.&nbsp; The patient has no chronic medical conditions or prior surgeries.&nbsp; Her only medication is a prenatal vitamin.&nbsp; She does not use tobacco, alcohol, or recreational drugs.&nbsp; Vital signs are normal.&nbsp; BMI is 22 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Fetal heart tones are 160/min.&nbsp; Ultrasound reveals a single intrauterine fetus measuring 14 weeks gestation.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T35330\" style=\"overflow-x:auto;\" tid=\"11007\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Cervical insufficiency</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Collagen defects</li><li>Uterine abnormalities</li><li>Cervical conization</li><li>Obstetric injury</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>&#8805;2 prior painless, 2nd-trimester losses</li><li>Painless cervical dilation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Cerclage placement</li></ul></td></tr></tbody></table></div><p>This patient has cervical insufficiency, a structural weakness of the cervix that predisposes to <a href=\"4711\">second-trimester pregnancy loss</a>.&nbsp; It is diagnosed by any 1 of the following criteria:</p><ul><li>Painless cervical dilation in the current pregnancy (ie, examination-based) OR</li><li>A second-trimester cervical length of &#8804;2.5 cm plus a prior preterm delivery (ie, ultrasound-based) OR</li><li><strong>&#8805;2 prior consecutive, painless, second-trimester losses</strong> (ie, history-based), which typically present with mild symptoms (eg, vaginal discharge, light spotting) followed by precipitous delivery</li></ul><p>Because of the high risk of recurrence, patients with <strong>history-based cervical insufficiency</strong> are treated with <strong>prophylactic cerclage</strong>, a procedure in which a <a href=\"1307\">suture</a>&nbsp;is placed to reinforce and add tensile strength to the cervix.&nbsp; Prophylactic cerclage is performed in the first trimester (ie, 12-14 weeks gestation) in patients with a history of cervical insufficiency before it can recur in the second trimester <strong>(Choice E)</strong>.&nbsp; The suture is removed at term to allow vaginal delivery.</p><p><strong>(Choice A)</strong>&nbsp; <a href=\"6298\">Amniocentesis</a>&nbsp;is typically performed for fetal karyotype analysis in patients with suspected fetal aneuploidy (eg, abnormal first-trimester integrated screening test).&nbsp; It is not used in the management of cervical insufficiency because it increases the risk of preterm labor and preterm premature rupture of membranes.</p><p><strong>(Choice C)</strong>&nbsp; Fetal fibronectin (fFN), an extracellular matrix protein located between the maternal decidua and fetal chorion, is secreted whenever this interface is disrupted (ie, labor).&nbsp; Therefore, in patients with preterm contractions between 22 and 35 weeks gestation, fFN testing helps distinguish between preterm and false labor.&nbsp; However, fFN testing is not used in patients who are asymptomatic or at &lt;22 weeks gestation, such as this patient, because of a high rate of false-positive results.</p><p><strong>(Choice D)</strong>&nbsp; <a href=\"6261\">Pessaries</a>&nbsp;were once recommended to decrease tension on the cervix from the growing uterus; however, they do not improve obstetric outcomes (ie, no decrease in preterm delivery rates) and therefore are no longer used for management of cervical insufficiency.</p><p><strong>Educational objective:</strong><br>Cervical insufficiency, a structural weakness of the cervix, causes painless cervical dilation, resulting in second-trimester pregnancy loss.&nbsp; Patients with a history of cervical insufficiency are managed with a prophylactic cerclage performed in the first trimester to decrease the risk of recurrence.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 12133,
            "topic": "Incompetent cervix",
            "titleId": 12133,
            "title": "Incompetent cervix",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amniocentesis",
                    "choiceNumber": 1,
                    "correctTaken": 321,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cerclage placement",
                    "choiceNumber": 2,
                    "correctTaken": 3280,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal fibronectin testing",
                    "choiceNumber": 3,
                    "correctTaken": 379,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pessary placement",
                    "choiceNumber": 4,
                    "correctTaken": 32,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Routine prenatal care only",
                    "choiceNumber": 5,
                    "correctTaken": 988,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27015229",
                    "mediaDataId": 0,
                    "title": "Overview of cervical insufficiency: diagnosis, etiologies, and risk factors.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27015229",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24451674",
                    "mediaDataId": 0,
                    "title": "ACOG practice bulletin no. 142: cerclage for the management of cervical insufficiency.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24451674",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 59,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 5000,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 18450,
            "questionIndex": 19918,
            "questionText": "<p>A 39-year-old woman comes to the office due to vaginal spotting and a positive pregnancy test.&nbsp; The patient has no medical conditions, and her only surgery was a cesarean delivery 8 years ago.&nbsp; The patient was seen 2 days ago for vaginal spotting and had a quantitative &#946;-hCG level of 3,033 mIU/mL.&nbsp; Transvaginal ultrasound at that time showed a thickened endometrial stripe with no intrauterine pregnancy or adnexal masses.&nbsp; Today, she continues to have vaginal spotting but no pelvic pain or cramping.&nbsp; Vital signs are normal.&nbsp; Pelvic examination shows a minimal amount of dark red blood in the posterior vaginal vault.&nbsp; The quantitative &#946;-hCG level today is 3,582 mIU/mL, and the results of a repeat ultrasound are unchanged from the previous findings.&nbsp; Diagnostic dilation and curettage is performed and examination of the intrauterine contents reveals benign endometrial tissue and no chorionic villi.&nbsp; Which of the following is the most likely cause of this patient&#39;s presentation?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"4539\" src=\"https://www.uworld.com/media/highresdefault/L16263.png\"  ></p><p>The most common reason for early pregnancy monitoring is <strong>first-trimester bleeding</strong>, as in this patient with vaginal spotting.&nbsp; Initial evaluation is with transvaginal ultrasonography and serum &#946;-hCG measurement.&nbsp; This patient had an initial &#946;-hCG &lt;3,500 mIU/mL, which is <strong>below the discriminatory zone</strong>, or the threshold at which a gestational sac should be visible on ultrasound if the pregnancy is intrauterine.</p><p>Patients with pregnancies below the discriminatory zone often have nondiagnostic ultrasound findings (eg, small pseudosac [centrally located fluid collection], no adnexal masses) and therefore are diagnosed with a <strong>pregnancy of unknown location</strong>: the pregnancy could be intrauterine (viable or nonviable) or extrauterine (ie, ectopic).</p><p>Because over 99% of viable pregnancies (including early pregnancies below the discriminatory zone) have a &#8805;35% rise in &#946;-hCG in 48 hours, a repeat &#946;-hCG level can help with diagnosis.&nbsp; An <strong>abnormal rise in &#946;-hCG</strong> (&lt;35% increase in 48 hr), as in this patient, indicates either a nonviable intrauterine pregnancy or an ectopic pregnancy.&nbsp; Because a viable pregnancy is unlikely, patients with an abnormal rise in &#946;-hCG can undergo <strong>diagnostic dilation and curettage</strong>, which determines pregnancy location based on the <strong>intrauterine contents</strong>:</p><ul><li>An abnormal intrauterine pregnancy (including a recent complete spontaneous abortion) will have chorionic villi, a finding consistent with intrauterine placental development <strong>(Choice A)</strong>.</li><li>In contrast, the intrauterine contents associated with an <strong>ectopic pregnancy</strong> will have <strong>no chorionic villi</strong> due to extrauterine pregnancy implantation.</li></ul><p>Therefore, this patient with no chorionic villi on dilation and curettage has an ectopic pregnancy.&nbsp; Management is with either methotrexate or surgery.</p><p><strong>(Choice C)</strong>&nbsp; Gestational trophoblastic disease (eg, hydatidiform mole) causes vaginal bleeding and markedly elevated &#946;-hCG levels (eg, &gt;100,000 mIU/mL).&nbsp; Pathology would reveal enlarged, <a href=\"49632\">hydropic chorionic villi</a> due to the abnormal proliferation of trophoblastic tissue.</p><p><strong>(Choice D)</strong>&nbsp; Pseudocyesis is a rare disorder in which a patient has signs and/or symptoms of pregnancy (eg, abdominal enlargement, nausea, breast tenderness) but a negative pregnancy test.</p><p><strong>Educational objective:</strong><br>Patients with a pregnancy of unknown location and abnormally rising &#946;-hCG levels (&lt;35% in 48 hr) can undergo diagnostic dilation and curettage to distinguish between a nonviable intrauterine pregnancy and an ectopic pregnancy.&nbsp; Patients with an ectopic pregnancy have no chorionic villi on examination of the intrauterine contents.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4099,
            "topic": "Ectopic pregnancy",
            "titleId": 4099,
            "title": "Ectopic pregnancy",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Complete spontaneous abortion",
                    "choiceNumber": 1,
                    "correctTaken": 2478,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ectopic pregnancy",
                    "choiceNumber": 2,
                    "correctTaken": 8984,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Gestational trophoblastic disease",
                    "choiceNumber": 3,
                    "correctTaken": 3543,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pseudocyesis",
                    "choiceNumber": 4,
                    "correctTaken": 1767,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27166462",
                    "mediaDataId": 0,
                    "title": "Early pregnancy bleeding.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27166462",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25077500",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of ectopic pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25077500",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28620520",
                    "mediaDataId": 0,
                    "title": "Incidence, diagnosis and management of tubal and nontubal ectopic pregnancies: a review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28620520",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 115,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 16772,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 2412,
            "questionIndex": 2412,
            "questionText": "<p>A 24-year-old woman, gravida 2 para 1, comes to the office for a routine prenatal visit.&nbsp; The patient is at 37 weeks gestation based on her last menstrual period and first-trimester ultrasound.&nbsp; She has some irregular contractions but has had no vaginal bleeding or leakage of fluid.&nbsp; Fetal movement is normal.&nbsp; This pregnancy has been uncomplicated, and her last pregnancy ended with a term spontaneous vaginal delivery to a 4 kg (8 lb 8 oz) boy.&nbsp; The patient would like to have a vaginal delivery with this pregnancy.&nbsp; She has no chronic medical conditions and has had no previous surgeries.&nbsp; Vital signs are normal.&nbsp; Fetal heart tones are 135/min.&nbsp; Fundal height is 37 cm.&nbsp; Digital cervical examination reveals a closed cervix and an unengaged fetal presenting part.&nbsp; Ultrasonography shows a fundal placenta, an amniotic fluid index of 6 cm (normal &#8805;5 cm), and a fetus in incomplete breech presentation.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t41491\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>External cephalic version</strong></p></td></tr><tr><td><p align=\"center\"><strong>Procedure</strong></p></td><td><ul><li>Manual rotation of fetus to cephalic presentation</li><li>Decreases cesarean delivery rate</li></ul></td></tr><tr><td><p align=\"center\"><strong>Indications</strong></p></td><td><ul><li>Breech/transverse presentation</li><li>&ge;37 weeks gestation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Absolute</strong></p><p align=\"center\"><strong>contraindications </strong></p></td><td><ul><li>Contraindication to vaginal delivery<ul><li>Prior classical cesarean delivery</li><li>Prior extensive uterine myomectomy</li><li>Placenta previa</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Abruptio placentae</li><li>Intrauterine fetal demise</li><li>Emergency cesarean delivery</li></ul></td></tr></tbody></table></div><p><strong>Breech presentation</strong> occurs when the buttocks or feet are the fetal part closest to the maternal cervix.&nbsp; Risk factors include prematurity, multiparity, multiple gestation, uterine anomalies (eg, septate uterus), leiomyomas, placenta previa, and some fetal anomalies (eg, hydrocephaly).&nbsp; Breech presentation is typically diagnosed via ultrasound; however, examination findings consistent with a breech fetus include subcostal pain or a palpation of a hard mass near the uterine fundus (due to the fetal head) or lack of a fetal presenting part on digital cervical examination.</p><p>Patients with breech presentation and <strong>no contraindications to vaginal delivery</strong> (eg, placenta previa, prior classical cesarean delivery) are offered <strong>external cephalic version</strong> (ECV), a procedure in which the fetus is <a href=\"1183\">manually rotated</a> to cephalic presentation <strong>(Choice A)</strong>.&nbsp; If the fetus is successfully rotated to cephalic presentation, patients can attempt a vaginal delivery.&nbsp; ECV has a risk of prelabor rupture of membranes, abruptio placentae, and preterm labor that may necessitate delivery; therefore, the procedure is performed at <strong>&#8805;37 weeks gestation</strong> to decrease the risks associated with premature delivery.</p><p><strong>(Choices B and E)</strong>&nbsp; Vaginal delivery may be appropriate for select patients spontaneously laboring with a fetus in frank or <a href=\"1182\">complete breech presentation</a>.&nbsp; However, vaginal delivery is contraindicated in patients with footling or incomplete breech presentation (such as this patient) due to the risk of head entrapment through an incompletely dilated cervix after delivery of the body, which is an obstetric emergency.&nbsp; Because this patient desires a vaginal delivery, ECV should be attempted; however, if the procedure is unsuccessful, a scheduled cesarean delivery is indicated.</p><p><strong>(Choice D)</strong>&nbsp; <a href=\"4818\">Internal podalic version</a> facilitates vaginal delivery of the second twin by grasping the feet and performing a breech extraction.&nbsp; It is not indicated in the management of singleton gestations.</p><p><strong>Educational objective:</strong><br>Patients at &#8805;37 weeks gestation with breech presentation are offered external cephalic version, a procedure in which the fetus is manually rotated to cephalic presentation.&nbsp; Patients who have a successful procedure have lower cesarean delivery rates compared with those who are managed expectantly.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 19194,
            "topic": "Prenatal Care",
            "titleId": 19194,
            "title": "Prenatal Care",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Continue routine prenatal care only",
                    "choiceNumber": 1,
                    "correctTaken": 3302,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Induce breech vaginal delivery at 40 weeks gestation",
                    "choiceNumber": 2,
                    "correctTaken": 100,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Schedule an external cephalic version",
                    "choiceNumber": 3,
                    "correctTaken": 11311,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend an internal podalic version during labor",
                    "choiceNumber": 4,
                    "correctTaken": 413,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform a cesarean delivery at 39 weeks gestation",
                    "choiceNumber": 5,
                    "correctTaken": 1587,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23076883",
                    "mediaDataId": 0,
                    "title": "External cephalic version for breech presentation at term.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23076883",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27392035",
                    "mediaDataId": 0,
                    "title": "Maternal outcomes of term breech presentation delivery:  impact of successful external cephalic version in a nationwide sample of delivery admissions in the United States.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27392035",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26942387",
                    "mediaDataId": 0,
                    "title": "Practice bulletin no. 161:  external cephalic version.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26942387",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 285,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 16713,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 17038,
            "questionIndex": 18486,
            "questionText": "<p>A 21-year-old woman, gravida 1 para 0, at 20 weeks gestation comes to the office for fetal anatomy ultrasonography.&nbsp; Her initial prenatal visit was last week, and she has had no vaginal bleeding, contractions, or leakage of fluid.&nbsp; The patient had not realized she was pregnant because her menses are irregular, typically occurring only once every 2 or 3 months.&nbsp; She has no known medical conditions and takes no medications.&nbsp; Blood pressure is 146/98 mm Hg and pulse is 88/min.&nbsp; BMI is 30 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Ultrasonography reveals a large defect in the calvaria and meninges, with only a small cerebellum and brainstem, as seen in the image below.</p><p><img  draggable=\"false\" id=\"31573\" src=\"https://www.uworld.com/media/highresdefault/U47436.jpg\"  ></p><p>The remainder of the fetal anatomy appears normal.&nbsp; Amniotic fluid volume measures 26 cm (normal: &lt;24 cm).&nbsp; Which of the following maternal factors is most commonly associated with this fetal anomaly?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"31574\" src=\"https://www.uworld.com/media/highresdefault/L47436.jpg\"  ></p><p>This fetus has <strong>anencephaly</strong>, a severe open <strong>neural tube defect (NTD)</strong> of the calvaria and skin that leads to complete obliteration of the fetal cerebrum.&nbsp; Anencephaly is diagnosed by fetal ultrasonography, which typically reveals an absent cerebrum, a calvarial defect, an abnormal cerebellum or brainstem, and elevated amniotic fluid volume (polyhydramnios due to impaired fetal swallowing).&nbsp; Because of the severe amount of missing brain tissue, anencephaly is incompatible with life.&nbsp; Other NTDs (eg, myelomeningocele, in which the spinal cord and meninges are exposed) may be less severe and compatible with life.</p><p>NTDs occur when the fetal neural tube fails to close.&nbsp; Neural tube closure is a tightly regulated process dependent on folate metabolism.&nbsp; Therefore, <strong>inadequate maternal folate intake</strong> (folate deficiency) is a major <strong>risk factor</strong> for NTDs.&nbsp; Because neural tube closure occurs at 5-6 weeks gestation, when most patients are unaware of their pregnancy (particularly if menses are irregular, as in this woman), all patients should begin folic acid supplementation at least 1 month before conception to ensure adequate folate levels.&nbsp; Average-risk patients require 0.4 mg daily; high-risk patients (eg, prior affected pregnancy, antiepileptic use) require 4 mg daily.</p><p><strong>(Choice B)</strong>&nbsp; Incomplete vaccination against rubella or varicella increases the risk for congenital infection, which can present with fetal growth restriction (rubella) or microcephaly (varicella) on ultrasonography.&nbsp; Neither presentation is associated with anencephaly.</p><p><strong>(Choice C)</strong>&nbsp; Poorly controlled hypertension, as in this patient, increases the risk for fetal growth restriction, placental abruption, preeclampsia, and preterm delivery.&nbsp; It does not increase the risk for NTDs.</p><p><strong>(Choice D)</strong>&nbsp; Undercooked meat consumption is associated with congenital toxoplasmosis, which can present with microcephaly, hydrocephalus, and diffuse cerebral calcifications on ultrasonography.&nbsp; It does not cause NTDs.</p><p><strong>(Choice E)</strong>&nbsp; Some untreated sexually transmitted infections such as syphilis and herpes simplex virus (HSV) increase the risk for congenital infection, which may present as hydrocephalus (syphilis) or microcephaly (HSV) on ultrasonography.&nbsp; These conditions are not associated with anencephaly.</p><p><strong>Educational objective:</strong><br>Inadequate maternal folate intake is a major risk factor for fetal neural tube defects (eg, anencephaly).&nbsp; Anencephaly is diagnosed by fetal ultrasonography, which typically reveals an absent cerebrum, a calvarial defect, an abnormal cerebellum or brainstem, and polyhydramnios.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 12760,
            "topic": "Neural tube defects",
            "titleId": 12760,
            "title": "Neural tube defects",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Inadequate folate intake",
                    "choiceNumber": 1,
                    "correctTaken": 4648,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Incomplete vaccination status",
                    "choiceNumber": 2,
                    "correctTaken": 115,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Poorly controlled hypertension",
                    "choiceNumber": 3,
                    "correctTaken": 90,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Undercooked meat consumption",
                    "choiceNumber": 4,
                    "correctTaken": 64,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Untreated sexually transmitted infection",
                    "choiceNumber": 5,
                    "correctTaken": 79,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29189693",
                    "mediaDataId": 0,
                    "title": "Practice bulletin no. 187: neural tube defects.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29189693",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28097362",
                    "mediaDataId": 0,
                    "title": "Folic acid supplementation for the prevention of neural tube defects: US Preventive Services Task Force recommendation statement.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28097362",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 143,
            "othersAvgTimeSpent": 62,
            "notes": null,
            "peopleTaken": 5063,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 92,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 11279,
            "questionIndex": 12434,
            "questionText": "<p>A 33-year-old woman, gravida 1 para 0, at 27 weeks gestation comes to the office for a prenatal visit.&nbsp; She had an ultrasound at 8 weeks gestation for pregnancy confirmation but has had no other prenatal care.&nbsp; Several weeks ago, the patient had a fever and a diffuse, nonpruritic, maculopapular rash that lasted 2 days and resolved without intervention.&nbsp; She has no chronic medical conditions.&nbsp; Vital signs are normal.&nbsp; Fundal height is 23 cm.&nbsp; Fetal heart rate is 160/min.&nbsp; Fetal ultrasound reveals bilateral ventriculomegaly and multiple intracranial calcifications within the basal ganglia and at the gray-white matter junction.&nbsp; Fetal ascites and hepatosplenomegaly are noted.&nbsp; Estimated fetal weight is below the 5th percentile for gestational age.&nbsp; This patient&#39;s presentation is most likely due to fetal infection from which of the following pathogens?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32140\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Congenital toxoplasmosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Maternal<br />risk factors</strong></p></td><td><ul><li>Raw or undercooked meat</li><li>Unwashed produce (ie, contaminated soil)</li><li>Handling of cat feces</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Classic triad:<ul style=\"list-style-type:circle;\"><li>Chorioretinitis</li><li>Diffuse intracranial calcifications</li><li>Hydrocephalus</li></ul></li></ul><ul><li>Microcephaly (brain atrophy) or macrocephaly (severe hydrocephalus)</li><li>Seizures</li><li>Nonspecific findings: jaundice, hepatosplenomegaly, rash, growth restriction</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li><em>Toxoplasma</em> serology or PCR</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Pyrimethamine, sulfadiazine, folinic acid</li></ul></td></tr><tr><td colspan=\"2\"><strong>PCR</strong> = polymerase chain reaction.</td></tr></tbody></table></div><p>This patient&#39;s ultrasound findings are suggestive of <strong>congenital toxoplasmosis</strong>.&nbsp; Maternal <em>Toxoplasma gondii</em> infection can occur via consumption of undercooked, contaminated meat or through contact with the feces of an infected cat, which is the definitive host of the protozoan oocysts.&nbsp; Although often asymptomatic, adults can have fever, lymphadenopathy, myalgias, and/or a diffuse, nonpruritic, maculopapular rash that resolves spontaneously, as seen in this patient.</p><p>Although maternal infection is mild, <strong>transplacental (vertical) transmission</strong> can result in devastating fetal infection.&nbsp; <em>T gondii</em> preferentially destroys fetal neural tissue, which results in ultrasound findings of bilateral ventriculomegaly (ie, <strong>hydrocephalus</strong>) and <strong>diffuse parenchymal intracranial calcifications</strong>, particularly within the basal ganglia.&nbsp; Additional fetal findings associated with congenital toxoplasmosis are nonspecific and may include ascites, <strong>hepatosplenomegaly</strong>, and <strong>fetal growth restriction</strong> (weight &lt;10th percentile).</p><p>Patients should undergo amniocentesis for <em>T gondii</em> PCR testing of amniotic fluid to confirm the diagnosis.&nbsp; Prenatal antitoxoplasmal therapy (eg, pyrimethamine, sulfadiazine, folinic acid) may decrease the risk of neurologic sequelae such as chorioretinitis, seizures, and intellectual disability.</p><p><strong>(Choice A)</strong>&nbsp; Herpes simplex virus can be vertically transmitted, but mothers typically have painful genital ulcers rather than a diffuse rash.&nbsp; In addition, common ultrasound findings include calcifications of the placenta and umbilical cord, not the brain parenchyma.</p><p><strong>(Choice B)</strong>&nbsp; Maternal infection with <em>Listeria monocytogenes</em> typically presents with a febrile gastroenteritis.&nbsp; Vertical transmission usually causes sepsis in the neonatal period due to exposure during delivery, but transplacental transmission can occur, typically causing disseminated abscesses, not intracranial calcifications.</p><p><strong>(Choice C)</strong>&nbsp; Parvovirus B19 can cause mild illness with a diffuse rash in adults, and ascites due to fetal hydrops may occur.&nbsp; However, other abnormal fluid collections (eg, pericardial/pleural effusion) are typical, and intracranial calcifications are not associated with this condition.</p><p><strong>(Choice E)</strong>&nbsp; Vertical transmission of varicella-zoster virus results in congenital varicella syndrome, which can cause growth restriction but typically presents with limb abnormalities (eg, bone/muscle hypoplasia).&nbsp; Although cortical atrophy can occur, intracranial calcifications are not seen.</p><p><strong>Educational objective:</strong><br>Vertical transmission of maternal infection with <em>Toxoplasma gondii</em> can result in fetal infection with characteristic fetal ultrasound findings of hydrocephalus and intracranial calcifications, particularly in the basal ganglia.&nbsp; Nonspecific findings of hepatosplenomegaly and fetal growth restriction are also common.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 8889,
            "topic": "Toxoplasmosis",
            "titleId": 8889,
            "title": "Toxoplasmosis",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Herpes simplex virus",
                    "choiceNumber": 1,
                    "correctTaken": 476,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>Listeria monocytogenes</em>",
                    "choiceNumber": 2,
                    "correctTaken": 419,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Parvovirus B19",
                    "choiceNumber": 3,
                    "correctTaken": 3432,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>Toxoplasma gondii</em>",
                    "choiceNumber": 4,
                    "correctTaken": 11388,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Varicella-zoster virus",
                    "choiceNumber": 5,
                    "correctTaken": 909,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21706510",
                    "mediaDataId": 0,
                    "title": "Prenatal brain imaging in congenital toxoplasmosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21706510",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27722099",
                    "mediaDataId": 0,
                    "title": "Congenital toxoplasmosis: clinical features, outcomes, treatment, and prevention.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27722099",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 175,
            "othersAvgTimeSpent": 59,
            "notes": null,
            "peopleTaken": 16624,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 21210,
            "questionIndex": 22715,
            "questionText": "<p>A 34-year-old woman, gravida 3 para 2, at 31 weeks gestation comes to the emergency department due to a lack of fetal movement for the past day.&nbsp; The patient has had no contractions, vaginal bleeding, or leakage of fluid.&nbsp; She has had an uncomplicated pregnancy but missed several appointments and was last evaluated at 20 weeks gestation.&nbsp; The patient has no chronic medical conditions and does not use tobacco, alcohol, or recreational drugs.&nbsp; Her last 2 pregnancies resulted in term spontaneous vaginal deliveries with no complications.&nbsp; Vital signs are normal.&nbsp; Transabdominal ultrasound confirms an intrauterine fetal demise.&nbsp; The patient undergoes induction of labor and has a vaginal delivery of a stillborn male fetus with no gross abnormalities.&nbsp; The patient asks how to prevent this from happening in future pregnancies.&nbsp; Which of the following is the most appropriate response?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Stillbirth</strong>, or intrauterine fetal demise, refers to fetal death at &#8805;20 weeks gestation occurring prior to delivery.&nbsp; Patients with a previous stillbirth are 2-10 times more likely to have another.&nbsp; However, the exact <strong>risk for recurrence</strong> and appropriate <strong>prevention strategies</strong> (eg, increased antenatal surveillance) indicated during future pregnancies will <strong>depend on the underlying cause</strong> of the first stillbirth <strong>(Choice E)</strong>.</p><p>The pathophysiology of stillbirth can be fetal, placental, or maternal in origin.&nbsp; Two of the highest-yield tests for identifying the cause are <strong>placental evaluation</strong> and <strong>fetal autopsy</strong>.&nbsp; Gross and microscopic placental evaluation can reveal evidence of placental thrombosis, abruption, infection, and other placental disease.&nbsp; Fetal autopsy can estimate the time of death, identify anatomic anomalies, and facilitate additional genetic studies.</p><p>Patients who decline fetal autopsy are still recommended to undergo noninvasive fetal evaluation (eg, external examination for dysmorphic features, MRI) and evaluation of the placenta, fetal membranes, and umbilical cord.&nbsp; In addition, maternal testing for other <a href=\"9457\">causes of stillbirth</a> (eg, antiphospholipid antibody syndrome, fetomaternal hemorrhage) should be performed.&nbsp; However, even after thorough evaluation, up to half of stillbirths have no identifiable cause.</p><p><strong>(Choice B)</strong>&nbsp; Kick counting has not been shown to prevent stillbirth recurrence, and recommending more frequent prenatal visits is inappropriate without knowing the cause of this patient&#39;s stillbirth.&nbsp; In addition, this response lacks empathy and places blame on the patient for missing prior appointments.</p><p><strong>(Choice C)</strong>&nbsp; This patient at 31 weeks gestation delivered a preterm, stillborn infant.&nbsp; Typically, progesterone supplementation is indicated for patients with a prior preterm delivery to prevent recurrence, but this applies only to patients with a prior <em>spontaneous</em> preterm delivery; this patient had an iatrogenic preterm delivery for a specific medical indication (ie, stillbirth).&nbsp; In addition, progesterone does not decrease the risk for stillbirth.</p><p><strong>(Choice D)</strong>&nbsp; Initiating daily low-dose aspirin during the second trimester decreases the risk for preeclampsia in patients with risk factors (eg, chronic hypertension).&nbsp; Preeclampsia is unlikely to be the cause of this patient&#39;s stillbirth because she has normal vital signs.&nbsp; In addition, further evaluation of the stillbirth should be performed prior to making recommendations for the next pregnancy.</p><p><strong>Educational objective:</strong><br>Identifying the cause of stillbirth (intrauterine fetal demise) helps determine the risk for recurrence and prevention strategies for future pregnancies.&nbsp; Evaluation should include fetal autopsy, genetic testing, placental examination, and maternal testing.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23772,
            "topic": "IUFD",
            "titleId": 23772,
            "title": "IUFD",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "&#x22;Although this is a hard decision, a fetal autopsy and placental evaluation may help us assess the future risk more clearly.&#x22;",
                    "choiceNumber": 1,
                    "correctTaken": 11964,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;We may be able to prevent this in the future with more frequent prenatal visits and earlier kick counts.&#x22;",
                    "choiceNumber": 2,
                    "correctTaken": 2966,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;When you begin trying for pregnancy again, we can start you on a progesterone supplement to help decrease your risk.&#x22;",
                    "choiceNumber": 3,
                    "correctTaken": 151,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;With your next pregnancy, we can initiate low-dose aspirin in the second trimester, which may help prevent this from happening again.&#x22;",
                    "choiceNumber": 4,
                    "correctTaken": 210,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Your risk for fetal demise in future pregnancies is very small, so there is nothing we can do to prevent this.&#x22;",
                    "choiceNumber": 5,
                    "correctTaken": 1393,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27781317",
                    "mediaDataId": 0,
                    "title": "Stillbirth and intrauterine fetal death: factors affecting determination of cause of death at autopsy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27781317",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27781319",
                    "mediaDataId": 0,
                    "title": "Stillbirth and intrauterine fetal death: role of routine histopathological placental findings to determine cause of death.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27781319",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30269876",
                    "mediaDataId": 0,
                    "title": "Awareness of fetal movements and care package to reduce fetal mortality (AFFIRM): a stepped wedge, cluster-randomised trial.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30269876",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 157,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 16684,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 72,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 3117,
            "questionIndex": 3117,
            "questionText": "<p>A 27-year-old woman, gravida 1 para 1, is evaluated on the postpartum floor due to a generalized tonic-clonic seizure that occurred 30 hours after a vaginal delivery.&nbsp; The patient was induced at 37 weeks gestation for preeclampsia with severe features via an oxytocin infusion for 48 hours.&nbsp; She also received magnesium sulfate for maternal seizure prophylaxis, which was discontinued 24 hours after delivery.&nbsp; The patient had a spontaneous vaginal delivery complicated by a postpartum hemorrhage that was treated with bimanual uterine massage and an oxytocin bolus and infusion.&nbsp; Temperature is 37.1 C (98.7 F), blood pressure is 128/82 mm Hg, pulse is 78/min, and respirations are 18/min.&nbsp; Physical examination shows a lethargic patient with no focal neurologic deficits.&nbsp; Laboratory results on serum drawn immediately after the seizure are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">10 g/dL</td><td style=\"width:243.75pt;\"></td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">160,000/mm<font size=\"2\"><sup>3</sup></font></td><td style=\"width:243.75pt;\"></td></tr><tr><td style=\"vertical-align:middle;\">Sodium</td><td style=\"vertical-align:middle;\">112 mEq/L</td><td style=\"width:243.75pt;\"></td></tr><tr><td style=\"vertical-align:middle;\">Potassium</td><td style=\"vertical-align:middle;\">3.6 mEq/L</td><td style=\"width:243.75pt;\"></td></tr><tr><td style=\"vertical-align:middle;\">Chloride</td><td style=\"vertical-align:middle;\">100 mEq/L</td><td style=\"width:243.75pt;\"></td></tr><tr><td style=\"vertical-align:middle;\">Magnesium</td><td style=\"vertical-align:middle;\">5.1 mg/dL</td><td style=\"width:243.75pt;\">(normal therapeutic range: 4.8-8.4 mg/dL)</td></tr></tbody></table><p>Which of the following is the most likely underlying cause of this patient&#39;s seizure?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient had a generalized tonic-clonic seizure after an induction of labor for preeclampsia with severe features.&nbsp; The most common cause of <strong>postpartum seizure</strong> is eclampsia; however, given this patient&#39;s normal blood pressure and magnesium level that is in the therapeutic range for preeclampsia/eclampsia&nbsp;management, other causes require evaluation.&nbsp; With a sodium level of 112 mEq/L, this patient&#39;s seizure is mostly likely due to <strong>severe hyponatremia</strong>, a rare <strong>side effect</strong> of oxytocin.</p><p><strong>Oxytocin</strong>, commonly used for induction of labor and postpartum hemorrhage management, has a similar structure to <strong>antidiuretic hormone</strong> (vasopressin); therefore, elevated levels can stimulate the renal collecting ducts to increase free water absorption.&nbsp; This leads to acute hyponatremia, decreased serum osmolality, and increased free water movement into the brain cells with resultant cerebral edema and seizure.&nbsp; The risk of this rare but life-threatening side effect is increased with <strong>excessive</strong> or <strong>prolonged oxytocin administration</strong>, as seen in this patient who had a 48-hour oxytocin infusion followed by a bolus.</p><p>Management of oxytocin-induced hyponatremia includes cessation of oxytocin infusion and gradual administration of hypertonic saline (eg, 3% saline) in symptomatic patients (eg, seizures) to raise serum osmolality and reverse cerebral edema.</p><p><strong>(Choice A)</strong>&nbsp; Acute blood loss anemia from postpartum hemorrhage can cause pituitary infarction (ie, Sheehan syndrome).&nbsp; Sheehan syndrome typically has a delayed presentation of nonspecific symptoms such as fatigue and decreased lactation, not an isolated seizure.</p><p><strong>(Choice B)</strong>&nbsp; Alcohol withdrawal can cause tonic-clonic seizures.&nbsp; Alcohol withdrawal seizures typically occur 12-48 hours after the last alcoholic drink and are not usually associated with severe hyponatremia.</p><p><strong>(Choice C)</strong>&nbsp; Intracerebral hemorrhage from hypertensive crisis (eg, uncontrolled preeclampsia) may present with seizures.&nbsp; However, patients typically have focal neurologic deficits and severely elevated blood pressure (ie, systolic &#8805;160 or diastolic &#8805;110 mm Hg), which are not seen in this patient.</p><p><strong>(Choice D)</strong>&nbsp; Although magnesium sulfate toxicity (ie, &#8805;8.4 mg/dL) can cause hyporeflexia, lethargy, respiratory failure, and eventual cardiac arrest, it does not cause seizure.&nbsp; In addition, this patient&#39;s level is within the therapeutic range.</p><p><strong>Educational objective:</strong><br>Because oxytocin has a similar structure to antidiuretic hormone, prolonged or excessive oxytocin administration can cause severe hyponatremia, cerebral edema, and generalized tonic-clonic seizures.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4691,
            "topic": "Hyponatremia",
            "titleId": 4691,
            "title": "Hyponatremia",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute blood loss anemia",
                    "choiceNumber": 1,
                    "correctTaken": 1978,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Alcohol withdrawal",
                    "choiceNumber": 2,
                    "correctTaken": 1200,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intracerebral hemorrhage",
                    "choiceNumber": 3,
                    "correctTaken": 2553,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Magnesium sulfate toxicity",
                    "choiceNumber": 4,
                    "correctTaken": 1224,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oxytocin side effect",
                    "choiceNumber": 5,
                    "correctTaken": 9722,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19397503",
                    "mediaDataId": 0,
                    "title": "Oxytocin infusion: acute hyponatraemia, seizures and coma.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19397503",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 131,
            "othersAvgTimeSpent": 79,
            "notes": null,
            "peopleTaken": 16696,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 12777,
            "questionIndex": 14073,
            "questionText": "<p>A 29-year-old woman, gravida 2 para 1, at 41 weeks gestation comes to the office for a routine prenatal visit.&nbsp; The patient has had no abdominal pain, leakage of fluid, or vaginal bleeding.&nbsp; Fetal movement is normal.&nbsp; The patient has had an uncomplicated pregnancy.&nbsp; An anatomy ultrasound at 20 weeks gestation was normal.&nbsp; Group B <em>Streptococcus</em> screening at 37 weeks gestation was negative.&nbsp; Her prior pregnancy ended in a post-term vaginal delivery.&nbsp; The patient has no chronic medical conditions and does not use tobacco, alcohol, or illicit drugs.&nbsp; Blood pressure is 120/70 mm Hg and pulse is 72/min.&nbsp; BMI is 29 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Fundal height is 37 cm.&nbsp; Nonstress test shows moderate variability, multiple accelerations, and no decelerations.&nbsp; Ultrasound reveals a fetus in vertex presentation, and the single deepest pocket of amniotic fluid is 1.2 cm.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t41381\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Late-term &amp; postterm pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>Late-term: &ge;41 weeks gestation</li><li>Post-term: &ge;42 weeks gestation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Prior postterm pregnancy</li><li>Nulliparity</li><li>Obesity</li><li>Age &ge;35</li><li>Fetal anomalies (eg, anencephaly)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Fetal/neonatal<ul style=\"list-style-type:circle;\"><li>Macrosomia</li><li>Dysmaturity syndrome</li><li>Oligohydramnios</li><li>Demise</li></ul></li><li>Maternal<ul style=\"list-style-type:circle;\"><li>Severe obstetric laceration</li><li>Cesarean delivery</li><li>Postpartum hemorrhage</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Frequent fetal monitoring (eg, nonstress test)</li><li>Delivery prior to 43 weeks gestation</li></ul></td></tr></tbody></table></div><p>Patients with <strong>late-term (&#8805;41 weeks gestation)</strong> and post-term (&#8805;42 weeks gestation) pregnancies are at increased risk for maternal and fetal complications.&nbsp; Maternal complications, such as postpartum hemorrhage and perineal lacerations, are due to increasing fetal growth (ie, macrosomia) associated with increasing gestational age.&nbsp; <strong>Fetal complications</strong> are due to age-related placental changes (eg, infarctions, calcifications) that result in uteroplacental insufficiency, fetal hypoxemia, and possible intrauterine fetal demise.</p><p>Due to the risk of fetal complications, patients with late-/post-term pregnancies undergo fetal monitoring with a nonstress test and amniotic fluid volume to evaluate for uteroplacental insufficiency.&nbsp; Signs of <strong>uteroplacental insufficiency</strong> include late decelerations on nonstress test and/or <strong>oligohydramnios</strong> on ultrasound (ie, <strong>single deepest pocket &lt;2 cm</strong>).&nbsp; Oligohydramnios occurs due to uteroplacental insufficiency because fetal blood is shunted from the kidney (which produces amniotic fluid) to the brain to prevent central nervous system suppression from chronic fetal hypoxemia.</p><p>In patients with a late-/post-term pregnancy and oligohydramnios on ultrasound or an abnormal nonstress test, immediate delivery is indicated due to the <strong>risk of intrauterine fetal demise</strong>.&nbsp; This patient has a reactive nonstress test and vertex presentation and can therefore undergo an <strong>induction of labor</strong>.</p><p><strong>(Choice A)</strong>&nbsp; An amnioinfusion is used in the management of variable decelerations, which typically occur secondary to oligohydramnios from rupture of membranes and subsequent fetal cord compression.&nbsp; This patient&#39;s oligohydramnios is due to chronic placental insufficiency and has no associated variable decelerations; therefore, amnioinfusion is not indicated.</p><p><strong>(Choices B and D)</strong>&nbsp; A biophysical profile and contraction stress test are performed to assess fetal well-being.&nbsp; This patient&#39;s oligohydramnios complicating a post-term pregnancy, already meets the criteria for delivery; therefore, additional evaluation of fetal well-being is not required as it does not change management.</p><p><strong>(Choice C)</strong>&nbsp; Cesarean delivery is indicated in patients with abnormal fetal heart tracings (eg, late decelerations) or fetal malpresentation (eg, breech), neither of which is seen in this patient.</p><p><strong>(Choice F)</strong>&nbsp; Patients with late-/post-term pregnancies and normal amniotic fluid volume (single deepest pocket &#8805;2 and &lt;8 cm) can continue routine prenatal care until &#8805;42 weeks gestation.</p><p><strong>Educational objective:</strong><br>Late-/post-term pregnancies are at increased risk for uteroplacental insufficiency and intrauterine fetal demise.&nbsp; Therefore, these patients undergo routine fetal monitoring with a nonstress test and amniotic fluid volume.&nbsp; Patients with oligohydramnios, a marker for placental insufficiency, require immediate delivery.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 12035,
            "topic": "Postterm pregnancy",
            "titleId": 12035,
            "title": "Postterm pregnancy",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amnioinfusion",
                    "choiceNumber": 1,
                    "correctTaken": 949,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Biophysical profile",
                    "choiceNumber": 2,
                    "correctTaken": 2095,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cesarean delivery",
                    "choiceNumber": 3,
                    "correctTaken": 889,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Contraction stress test",
                    "choiceNumber": 4,
                    "correctTaken": 332,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Induction of labor",
                    "choiceNumber": 5,
                    "correctTaken": 10863,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Routine prenatal visit in 1 week",
                    "choiceNumber": 6,
                    "correctTaken": 1493,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26094600",
                    "mediaDataId": 0,
                    "title": "Single deepest vertical pocket or amniotic fluid index as evaluation test for predicting adverse pregnancy outcome (SAFE trial):  a multicenter, open-label, randomized controlled trial.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26094600",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25050770",
                    "mediaDataId": 0,
                    "title": "Practice bulletin no. 146:  management of late-term and postterm pregnancies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25050770",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 183,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 16621,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 3510,
            "questionIndex": 3510,
            "questionText": "<p>A 32-year-old woman, gravida 2 para 1, at 37 weeks gestation is undergoing a prolonged induction of labor for a twin pregnancy.&nbsp; During the induction, the patient abruptly loses consciousness, has stiffness of the arms and legs, and then begins to have muscle jerking.&nbsp; She is unresponsive for several minutes, but slowly regains consciousness.&nbsp; The patient has been receiving an oxytocin infusion for the last 8 hours, and epidural analgesia was placed several hours ago after spontaneous rupture of membranes.&nbsp; She has no chronic medical conditions and takes no daily medications.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 158/98 mm Hg, pulse is 118/min, and respirations are 24/min.&nbsp; The patient is alert but disoriented.&nbsp; The neck is supple.&nbsp; Heart sounds are regular, and the lungs are clear to auscultation bilaterally.&nbsp; Patellar deep tendon reflexes are 3+, and there are no focal neurologic deficits.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">10 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">90,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">14,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td style=\"vertical-align:middle;\">134 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td style=\"vertical-align:middle;\">3.6 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Chloride</td><td style=\"vertical-align:middle;\">104 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Bicarbonate&nbsp;</td><td style=\"vertical-align:middle;\">20 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td style=\"vertical-align:middle;\">0.7 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td style=\"vertical-align:middle;\">80 mg/dL</td></tr></tbody></table><p>Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T68143\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Eclampsia</strong></p><p align=\"center\"><strong>(preeclampsia + new-onset seizure)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Hypertension, typically severe (ie, SBP &#8805;160 or DBP &#8805;110 mm Hg)</li><li>Seizure, typically tonic-clonic with postictal phase</li><li>Severe headache</li><li>Visual disturbances (ie, scotoma)</li><li>Hyperreflexia</li><li>Proteinuria</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Mainly clinical</li><li>Bilateral frontal lobe edema on CT scan of the head</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Magnesium sulfate infusion</li><li>Antihypertensive agent for severe hypertension</li><li>Delivery</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>DBP</strong> = diastolic blood pressure; <strong>SBP</strong> = systolic blood pressure.</p></td></tr></tbody></table></div><p>This laboring patient with tonic-clonic seizure likely has <strong>eclampsia</strong>.&nbsp; Eclampsia is the presumptive diagnosis in pregnant patients with <strong>new-onset seizure</strong> and <strong>preeclampsia with severe features</strong>, as in this patient with hypertension (ie, systolic &#8805;140 or diastolic &#8805;90 mm Hg in pregnancy) and thrombocytopenia (platelet count &lt;100,000/mm<font size=\"2\"><sup>3</sup></font>).&nbsp; Preeclampsia likely occurs due to an abnormal placenta that releases antiangiogenic factors, causing maternal endothelial dysfunction in the brain (eg, brain ischemia, seizure) and other end organs.</p><p>Eclampsia is classically preceded by severe headache or visual disturbances (eg, blurred vision, scotomata).&nbsp; However, not all patients have preceding neurologic symptoms.&nbsp; Eclamptic seizures are typically <strong>tonic-clonic, generalized</strong>, and <strong>brief</strong>, lasting up to a few minutes and followed by a postictal phase.&nbsp; During the postictal phase (typically lasting 10-20 min), the patient may be unresponsive, confused/disoriented, or drowsy.&nbsp; There are typically no associated focal neurologic deficits.</p><p>Eclampsia is a clinical diagnosis; however, brain imaging (eg, CT scan of the head) can be performed to exclude other causes of seizure.&nbsp; Because of the risk of seizure recurrence and maternal complications (eg, stroke), patients with eclampsia require <strong>prompt delivery</strong> because removal of the placenta is typically curative.&nbsp; Patients also require magnesium sulfate infusion to reduce the risk of seizure recurrence.</p><p><strong>(Choice A)</strong>&nbsp; Oxytocin and antidiuretic hormone share a similar structure; therefore, prolonged or excessive oxytocin administration (eg, labor induction) can cause severe hyponatremia, leading to cerebral edema and seizure.&nbsp; This patient&#39;s only mild hyponatremia&nbsp;makes&nbsp;this diagnosis unlikely.</p><p><strong>(Choice B)</strong>&nbsp; This patient with preeclampsia and new-onset seizure most likely has eclampsia and requires urgent delivery; however, if she continues to have seizures postpartum and brain imaging is normal, an electroencephalogram may be indicated to evaluate for other causes of seizure.</p><p><strong>(Choice C)</strong>&nbsp; Emergency intubation is indicated for inadequate oxygenation (eg, pulmonary edema), ventilation, or airway protection (eg, <a href=\"39370\">high spinal anesthesia</a>).&nbsp; In contrast, this patient is conscious with normal respirations and lung examination.</p><p><strong>(Choice D)</strong>&nbsp; Epidural removal is indicated for local anesthetic systemic toxicity (LAST), which can present with generalized tonic-clonic seizures.&nbsp; However, LAST is typically associated with cardiovascular collapse (eg, hypotension), not hypertension.</p><p><strong>Educational objective</strong>:<br>Patients with preeclampsia with severe features and new-onset seizure likely have eclampsia.&nbsp; Eclamptic seizures are typically tonic-clonic and generalized, last several minutes, and are associated with a postictal phase; there are usually no associated focal neurologic deficits.&nbsp; Treatment is with prompt delivery and magnesium sulfate infusion.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4219,
            "topic": "Preeclampsia",
            "titleId": 4219,
            "title": "Preeclampsia",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Discontinuation of oxytocin",
                    "choiceNumber": 1,
                    "correctTaken": 3071,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Electroencephalography",
                    "choiceNumber": 2,
                    "correctTaken": 152,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Emergent intubation",
                    "choiceNumber": 3,
                    "correctTaken": 632,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Epidural removal",
                    "choiceNumber": 4,
                    "correctTaken": 660,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prompt delivery",
                    "choiceNumber": 5,
                    "correctTaken": 12159,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21109107",
                    "mediaDataId": 0,
                    "title": "Seizures in pregnancy/eclampsia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21109107",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 300,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 16674,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 13200,
            "questionIndex": 14555,
            "questionText": "<p>A 32-year-old primigravid woman at 37 weeks gestation and in active labor is admitted to the labor and delivery unit.&nbsp; On admission, the cervix is 4 cm dilated and 80% effaced, with the fetal vertex at 0 station.&nbsp; The membranes are grossly ruptured with thin, clear amniotic fluid.&nbsp; Fetal heart rate tracing is category I, and the patient receives epidural anesthesia for pain management; she reports complete pain relief.&nbsp; The fetal heart rate tracing 10 minutes later is shown in the following image:</p><p><img draggable=\"false\" id=\"33278\" src=\"https://www.uworld.com/media/highresdefault/U58795.png\" ></p><p>Maternal blood pressure is 60/40 mm Hg and pulse is 60/min.&nbsp; Repeat cervical examination shows the cervix to be 5 cm dilated and 100% effaced and the fetal vertex at +1 station.&nbsp; In addition to intravenous fluids, which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"33279\" src=\"https://www.uworld.com/media/highresdefault/L58795.png\" ></p><p>This patient&#39;s fetal heart rate tracing shows <strong>late decelerations</strong>, a sign of decreased placental perfusion (ie, uteroplacental insufficiency) and impending fetal hypoxemia and acidemia.&nbsp; A common cause of decreased placental perfusion is <strong>maternal hypotension</strong>, a common side effect of <strong>neuraxial anesthesia</strong> (eg, epidural).</p><p>Epidural anesthesia typically consists of a local anesthetic (eg, bupivacaine) and an opioid (eg, fentanyl) for a targeted block of pain fibers associated with labor and delivery.&nbsp; However, epidurals can also cause <strong>sympathetic nerve blockade</strong>, which results in vasodilation, decreased venous return to the heart, decreased cardiac output, and resultant maternal hypotension.&nbsp; Therefore, patients are often given an intravenous fluid bolus prior to epidural placement, but hypotension still commonly occurs.</p><p>Treatment of maternal hypotension and uteroplacental insufficiency includes left uterine displacement (positioning the patient on her left side) to improve venous return, intravenous fluid bolus, and <strong>vasopressor administration</strong> (eg, <strong>phenylephrine</strong>, ephedrine) to improve blood pressure.&nbsp; Patients who continue to have late fetal decelerations despite these measures require cesarean delivery to prevent fetal hypoxemia.</p><p><strong>(Choice A)</strong>&nbsp; Amnioinfusion is used to reduce umbilical cord compression, which can occur after rupture of membranes and is evidenced by <a href=\"14217\">variable decelerations</a>.&nbsp; It is not used in the management of late decelerations.</p><p><strong>(Choice B)</strong>&nbsp; Opioids are used in neuraxial anesthesia and very rarely may cause systemic overdose, which can be treated with naloxone.&nbsp; However, patients rarely have profound hypotension, and the fetal heart rate tracing typically shows <a href=\"2157\">minimal variability</a> rather than recurrent late decelerations.</p><p><strong>(Choice D)</strong>&nbsp; Terbutaline is a tocolytic used to treat recurrent late decelerations due to <a href=\"20770\">uterine tachysystole</a>, defined as &gt;5 contractions/10 min.&nbsp; This patient&#39;s contraction frequency is normal.&nbsp; In addition, terbutaline is a beta-2 agonist and can cause vasodilation and hypotension, which would worsen this patient&#39;s condition.</p><p><strong>Educational objective:</strong><br>Neuraxial anesthesia (eg, epidural) can cause sympathetic block, resulting in maternal hypotension and decreased placental perfusion, as evidenced by recurrent late fetal heart rate decelerations.&nbsp; Management is with left lateral patient positioning, intravenous fluid bolus, and vasopressors (eg, phenylephrine).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23467,
            "topic": "Anesthesia",
            "titleId": 23467,
            "title": "Anesthesia",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amnioinfusion",
                    "choiceNumber": 1,
                    "correctTaken": 4327,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Naloxone",
                    "choiceNumber": 2,
                    "correctTaken": 1214,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Phenylephrine",
                    "choiceNumber": 3,
                    "correctTaken": 8017,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Terbutaline",
                    "choiceNumber": 4,
                    "correctTaken": 3144,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31741565",
                    "mediaDataId": 0,
                    "title": "Spinal anaesthesiainduced hypotension in obstetrics: prevention and therapy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31741565",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28976555",
                    "mediaDataId": 0,
                    "title": "Techniques for preventing hypotension during spinal anaesthesia for caesarean section.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28976555",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 52,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 16702,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 19530,
            "questionIndex": 21016,
            "questionText": "<p>A 28-year-old woman, gravida 1 para 0, at 35 weeks gestation comes to the emergency department due to nausea, vomiting, and right upper quadrant pain.&nbsp; The patient&#39;s symptoms began last night but have progressively worsened throughout the day.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 160/94 mm Hg, and pulse is 80/min.&nbsp; Physical examination shows right upper quadrant tenderness without rebound or guarding.&nbsp; Fetal heart rate tracing shows a baseline of 140 with moderate variability, no decelerations, and no accelerations.&nbsp; Cardiopulmonary examination is unremarkable.&nbsp; The abdomen is tender to palpation over the right upper quadrant; the uterus is nontender.&nbsp; There is 2+ edema of the lower extremities.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>8.5 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>96,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>1 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td>82 mg/dL</td></tr><tr><td colspan=\"2\">Liver function studies</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td>2.6 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Direct bilirubin</td><td>0.8 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td>120 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase (SGOT)</td><td>308 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase (SGPT)</td><td>265 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Lipase</td><td>53 U/L</td></tr><tr><td colspan=\"2\">Coagulation studies</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Prothrombin time</td><td>13 sec</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Activated partial thromboplastin time</td><td>25 sec</td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s presentation?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T32701\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>HELLP syndrome*</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical findings</strong></p></td><td><ul><li>Nausea/vomiting</li><li>Right upper quadrant pain</li><li>Headache</li><li>Visual changes</li><li>Hypertension</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory abnormalities</strong></p></td><td><ul><li>Microangiopathic hemolytic anemia</li><li>Elevated liver enzymes</li><li>Thrombocytopenia</li><li>&plusmn; Proteinuria</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Delivery</li><li>Magnesium sulfate for seizure prophylaxis</li><li>Antihypertensives (eg, hydralazine)&nbsp;</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Abruptio placentae</li><li>Subcapsular liver hematoma</li><li>Acute renal failure</li><li>Pulmonary edema</li><li>Disseminated intravascular coagulation</li></ul></td></tr><tr><td colspan=\"2\"><p style=\"margin-left:.05in;\">*HELLP (<strong>H</strong>emolysis, <strong>E</strong>levated <strong>L</strong>iver enzymes, <strong>L</strong>ow <strong>P</strong>latelet count).</p></td></tr></tbody></table></div><p>This patient at 35 weeks gestation likely has <strong>HELLP</strong> (<strong>H</strong>emolysis, <strong>E</strong>levated <strong>L</strong>iver enzymes, <strong>L</strong>ow <strong>P</strong>latelets) <strong>syndrome</strong>, a life-threatening disorder related to preeclampsia with severe features.&nbsp; Similar to preeclampsia, the etiology is likely <a href=\"38603\">abnormal placental development</a> during early pregnancy with the placental release of antiangiogenic factors; these abnormalities cause widespread maternal endothelial dysfunction and dysregulation of vascular tone (eg, new-onset hypertension).</p><p>HELLP syndrome is associated with systemic microangiopathy and excessive platelet consumption (likely due to severe endothelial injury) that leads to overactivation of the coagulation cascade and thrombi formation in the microvasculature.&nbsp; As platelets are consumed and platelet-fibrin thrombi form, patients develop <strong>thrombocytopenia</strong> and shearing of red blood cells by the widespread thrombi, resulting in <strong>microangiopathic hemolytic anemia</strong> (MAHA) (as evidenced by this patient&#39;s indirect hyperbilirubinemia), which is detrimental to the liver.&nbsp; The hepatocellular injury (from vasospasm and/or hepatic portal system thrombi) leads to distension of the hepatic (Glisson) capsule, causing worsening <strong>right upper quadrant pain</strong> with nausea, vomiting, and <strong>elevated transaminases</strong>.</p><p>Other potential complications include liver rupture, eclampsia, and intrauterine fetal demise.&nbsp; Patients with HELLP syndrome require prompt delivery because removal of the placenta is the only definitive cure.</p><p><strong>(Choice A)</strong>&nbsp; Acute fatty liver of pregnancy, the microvesicular fatty infiltration of hepatocytes, can cause elevated liver transaminases and thrombocytopenia.&nbsp; However, patients typically have fulminant hepatic failure (eg, prolonged prothrombin time and partial thromboplastin time, profound hypoglycemia), which is not seen in this patient.</p><p><strong>(Choice B)</strong>&nbsp; Immune thrombocytopenic purpura typically causes isolated thrombocytopenia and is a diagnosis of exclusion.&nbsp; It is not associated with MAHA.</p><p><strong>(Choice C)</strong>&nbsp; Intrahepatic cholestasis of pregnancy causes generalized pruritus, hyperbilirubinemia, and elevated transaminases due to impaired bile acid flow.&nbsp; However, it is not associated with hypertension, MAHA, or thrombocytopenia.</p><p><strong>(Choice D)</strong>&nbsp; Premature placental separation (ie, abruptio placentae) most commonly occurs in patients with preeclampsia or HELLP syndrome.&nbsp; It classically presents with severe uterine tenderness and fetal compromise due to decreased fetoplacental perfusion.&nbsp; In contrast, this patient has right upper quadrant pain, no uterine tenderness, and a reassuring fetal heart rate tracing (eg, normal baseline, moderate variability).</p><p><strong>Educational objective:</strong><br>HELLP (<strong>H</strong>emolysis, <strong>E</strong>levated <strong>L</strong>iver enzymes, <strong>L</strong>ow <strong>P</strong>latelets) syndrome can present with right upper quadrant pain, microangiopathic hemolytic anemia, elevated transaminases, and thrombocytopenia.&nbsp; The pathogenesis involves widespread endothelial dysfunction leading to microangiopathy, overactivation of the coagulation cascade, and excessive platelet consumption.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4219,
            "topic": "Preeclampsia",
            "titleId": 4219,
            "title": "Preeclampsia",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute microvesicular fatty infiltration of hepatocytes",
                    "choiceNumber": 1,
                    "correctTaken": 4163,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Antibody-mediated platelet destruction",
                    "choiceNumber": 2,
                    "correctTaken": 741,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intrahepatic cholestasis",
                    "choiceNumber": 3,
                    "correctTaken": 2019,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Premature placental separation",
                    "choiceNumber": 4,
                    "correctTaken": 203,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Systemic microangiopathy and platelet consumption",
                    "choiceNumber": 5,
                    "correctTaken": 9550,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32358352",
                    "mediaDataId": 0,
                    "title": "Clinical characteristics and pregnancy outcomes of atypical hemolysis, elevated liver enzymes, and low platelets syndrome: a case series.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32358352",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26634939",
                    "mediaDataId": 0,
                    "title": "The differential diagnosis of thrombocytopenia in pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26634939",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 167,
            "othersAvgTimeSpent": 83,
            "notes": null,
            "peopleTaken": 16676,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 57,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 16836,
            "questionIndex": 18282,
            "questionText": "<p>A 29-year-old woman, gravida 1 para 1, comes to the office for a routine postpartum visit.&nbsp; Six weeks ago, she delivered a 4.2-kg (9 lb 5 oz) girl by cesarean delivery for cephalopelvic disproportion.&nbsp; The pregnancy was complicated by gestational diabetes mellitus, which was controlled with diet and exercise, and preeclampsia without severe features.&nbsp; Since the delivery, the patient has been feeling well but continues to have daily light vaginal bleeding of dark red or brown blood.&nbsp; She is breastfeeding exclusively and is not on contraception.&nbsp; She has no chronic medical conditions and has had no other surgeries.&nbsp; Her last Pap test 2 years ago was normal.&nbsp; Blood pressure is 122/78 mm Hg and pulse is 87/min.&nbsp; BMI is 30 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The lower abdominal incision is well healed.&nbsp; On speculum examination, there is a small amount of scant brown discharge in the vaginal vault and no cervical lesions.&nbsp; The remainder of the physical examination is normal.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32380\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Gestational diabetes mellitus</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>Human placental lactogen secretion</li></ul></td></tr><tr><td><p align=\"center\"><strong>Screening</strong></p></td><td><ul><li>24-28 weeks gestation</li><li>1-hr 50-g GCT</li><li>3-hr 100-g GTT</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>1st line: diet</li><li>2nd line: insulin, glyburide, metformin</li></ul></td></tr><tr><td><p align=\"center\"><strong>Target blood glucose goals</strong></p></td><td><ul><li>Fasting: &le;95 mg/dL</li><li>1-hr postprandial: &le;140 mg/dL</li><li>2-hr postprandial: &le;120 mg/dL</li></ul></td></tr><tr><td><p align=\"center\"><strong>Postpartum management</strong></p></td><td><ul><li>Fasting glucose at 24-72 hr</li><li>2-hr 75-g GTT at 6- to 12-week visit</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>GCT</strong> = glucose challenge test; <strong>GTT</strong> = glucose tolerance test.</p></td></tr></tbody></table></div><p>This patient had <strong>gestational diabetes mellitus (GDM)</strong>, a common disorder due to placenta-mediated increases in peripheral insulin resistance.&nbsp; Patients are universally screened for GDM at 24-28 weeks gestation, and management varies from diet/exercise to insulin therapy, depending on the ability to achieve target blood glucose goals.</p><p>After delivery of the placenta, maternal insulin resistance decreases and blood glucose levels typically return to normal.&nbsp; However, all patients diagnosed with GDM are at <strong>increased risk</strong> for developing <strong>type 2 diabetes mellitus (T2DM)</strong> due to a proven predisposition toward insulin resistance.&nbsp; In addition, some patients diagnosed with GDM may have had undiagnosed (ie, preexisting) T2DM before becoming pregnant.&nbsp; For these reasons, all patients with GDM require <strong>postpartum screening</strong> with a <strong>2-hour (75-g) oral glucose tolerance test</strong> performed <strong>6-12 weeks after delivery</strong>.&nbsp; If screening is negative, repeat screening should occur at 3-year intervals.</p><p><strong>(Choice B)</strong>&nbsp; A 24-hour urine total protein collection can assess for preeclampsia, and an antepartum diagnosis of preeclampsia (as in this patient) increases the risk of persistent preeclampsia and eclampsia up to 12 weeks postpartum.&nbsp; However, this patient is currently normotensive, making these diagnoses unlikely and further testing is not required.</p><p><strong>(Choice C)</strong>&nbsp; This patient&#39;s daily, scant brown vaginal bleeding is consistent with normal lochia, a gradual process of endometrial shedding and regeneration which can last up to 8 weeks after delivery.&nbsp; Therefore, further evaluation with endometrial biopsy is not indicated.</p><p><strong>(Choice D)</strong>&nbsp; In women age &lt;30, routine cervical cancer screening occurs every 3 years with a Pap test only (ie, no HPV cotesting).&nbsp; This patient&#39;s Pap test was normal 2 years ago.</p><p><strong>(Choice E)</strong>&nbsp; Urine culture screening is performed routinely during pregnancy to identify and treat asymptomatic bacteriuria to help prevent acute pyelonephritis and preterm labor.&nbsp; In contrast, asymptomatic postpartum patients do not typically require urine culture screening because it does not change outcomes.</p><p><strong>Educational objective:</strong><br>Patients with gestational diabetes mellitus are at increased risk for developing type 2 diabetes mellitus.&nbsp; Therefore, these patients are screened with a 2-hour (75-g) oral glucose tolerance test at 6-12 weeks postpartum.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23383,
            "topic": "Postpartum complication",
            "titleId": 23383,
            "title": "Postpartum complication",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "2-hour (75-g) oral glucose tolerance test",
                    "choiceNumber": 1,
                    "correctTaken": 9541,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "24-hour total urine protein collection",
                    "choiceNumber": 2,
                    "correctTaken": 1248,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial biopsy",
                    "choiceNumber": 3,
                    "correctTaken": 3521,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pap test with human papillomavirus cotesting",
                    "choiceNumber": 4,
                    "correctTaken": 1031,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urine culture",
                    "choiceNumber": 5,
                    "correctTaken": 1397,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29370047",
                    "mediaDataId": 0,
                    "title": "ACOG practice bulletin no. 190: gestational diabetes mellitus.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29370047",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 99,
            "othersAvgTimeSpent": 75,
            "notes": null,
            "peopleTaken": 16738,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 57,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 14810,
            "questionIndex": 16233,
            "questionText": "<p>A 40-year-old woman, gravida 3 para 2, at 33 weeks gestation comes to labor and delivery due to leakage of fluid.&nbsp; The patient has had intermittent leakage of clear vaginal fluid for the past few hours but no vaginal bleeding.&nbsp; She also has had irregular contractions for the past few weeks but they are nonpainful.&nbsp; Fetal movement has been normal.&nbsp; The patient has type 2 diabetes mellitus and had polyhydramnios on her most recent fetal ultrasound examination.&nbsp; Her first 2 pregnancies were uncomplicated and ended in term vaginal deliveries.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 120/70 mm Hg, and pulse is 70/min.&nbsp; BMI is 35 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Fetal heart rate tracing shows a baseline of 140/min with moderate variability, multiple accelerations, and no decelerations.&nbsp; Tocodynamometer reveals contractions every 20-30 minutes.&nbsp; The uterus is nontender.&nbsp; Speculum examination shows a closed cervix and clear fluid in the posterior fornix of the vagina; ferning is noted on microscopy.&nbsp; Transabdominal ultrasound examination reveals a fetus in vertex presentation surrounded by minimal amniotic fluid; the deepest vertical pocket is 1 cm.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"5024\" src=\"https://www.uworld.com/media/highresdefault/L29779.png\"  ></p><p>This patient&#39;s vaginal pooling of fluid with ferning is consistent with <strong>preterm prelabor rupture of membranes (PPROM)</strong>, defined as ROM at &lt;37 weeks gestation <strong>prior to the onset of labor</strong> (as evidenced by her irregular contractions and closed cervix).&nbsp; Risk factors include prior PPROM and conditions that overdistend or weaken the membranes (eg, polyhydramnios, genitourinary tract infection, antepartum bleeding).</p><p>Management depends on gestational age and maternal-fetal status; benefits of further fetal development in utero (eg, fetal lung maturity) are balanced against risks for complications (eg, intraamniotic infection).&nbsp; In the absence of complications, patients with PPROM at <strong>&lt;34 weeks gestation</strong> require <strong>inpatient expectant management</strong> with:</p><ul><li><p><strong>prophylactic latency antibiotics</strong> to prevent fulminant intraamniotic infection, thereby increasing time between ROM and delivery (ie, &#x22;latency&#x22;).</p></li><li><p><strong>corticosteroids</strong> (eg, betamethasone) to decrease the risk of neonatal respiratory distress syndrome.</p></li><li><p>fetal surveillance (eg, nonstress test, fetal growth ultrasound examination).</p></li></ul><p>Patients with PPROM require delivery at 34 weeks gestation (when risk of complications exceeds neonatal risks associated with preterm delivery) or earlier in the event of complications (eg, placental abruption).</p><p><strong>(Choice A)</strong>&nbsp; Amnioinfusion replaces leaking amniotic fluid with normal saline.&nbsp; Although this patient has oligohydramnios (ie, deepest vertical pocket &lt;2 cm) due to PPROM, amnioinfusion for PPROM in the third trimester has not been shown to improve fetal outcomes.&nbsp; Amnioinfusion would be indicated for recurrent variable decelerations (caused by cord compression), which this patient does not have.</p><p><strong>(Choices B and C)</strong>&nbsp; Magnesium sulfate is given for fetal neuroprotection (ie, cerebral palsy risk reduction) for preterm deliveries at &lt;32 weeks gestation.&nbsp; This patient is at 33 weeks gestation.&nbsp; Tocolysis (eg, nifedipine) halts all contractions.&nbsp; It is commonly administered to patients in spontaneous early preterm labor (&lt;34 weeks gestation without ROM) to delay delivery while corticosteroids take effect.&nbsp; Tocolysis is typically not administered for PPROM because monitoring for increasing contractions is essential for the early detection and management of life-threatening PPROM complications (eg, intraamniotic infection, placental abruption).</p><p><strong>(Choice E)</strong>&nbsp; Vaginal progesterone may decrease the risk of preterm delivery in patients with an incidental shortened cervix (&#8804;25 mm), cervical insufficiency, or a history of preterm delivery.&nbsp; It is not used in the management of PPROM.</p><p><strong>Educational objective:</strong><br>Uncomplicated preterm prelabor rupture of membranes at &lt;34 weeks gestation is managed expectantly with prophylactic latency antibiotics, corticosteroids, and inpatient monitoring.&nbsp; Delivery is at 34 weeks gestation or earlier in the event of complications (eg, intraamniotic infection, placental abruption).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23687,
            "topic": "Preterm premature rupture of the membranes",
            "titleId": 23687,
            "title": "Preterm premature rupture of the membranes",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amnioinfusion",
                    "choiceNumber": 1,
                    "correctTaken": 4871,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Magnesium sulfate",
                    "choiceNumber": 2,
                    "correctTaken": 1229,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nifedipine tocolysis",
                    "choiceNumber": 3,
                    "correctTaken": 2973,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prophylactic latency antibiotics",
                    "choiceNumber": 4,
                    "correctTaken": 6994,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vaginal progesterone",
                    "choiceNumber": 5,
                    "correctTaken": 505,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "33093409",
                    "mediaDataId": 0,
                    "title": "ACOG practice bulletin no. 217: prelabor rupture of membranes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/33093409",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24683009",
                    "mediaDataId": 0,
                    "title": "Amnioinfusion for third trimester preterm premature rupture of membranes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24683009",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 127,
            "othersAvgTimeSpent": 78,
            "notes": null,
            "peopleTaken": 16572,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 42,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 11168,
            "questionIndex": 12318,
            "questionText": "<p>A 37-year-old woman, gravida 2 para 1, at 8 weeks gestation comes to the office for a follow-up visit.&nbsp; Earlier in the pregnancy, the patient had nausea and breast tenderness that resolved several days ago.&nbsp; She has no other concerns.&nbsp; At the initial prenatal visit 12 days ago, ultrasound revealed an intrauterine gestational sac with a yolk sac but no fetal pole.&nbsp; &#946;-hCG level at that visit was 27,325 IU/L.&nbsp; Current blood pressure is 140/80 mm Hg and pulse is 68/min.&nbsp; BMI is 23 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Pelvic examination reveals a closed cervix and no vaginal discharge or bleeding.&nbsp; Bimanual examination demonstrates a normal-sized, retroverted uterus with no cervical motion or adnexal tenderness.&nbsp; Transvaginal ultrasound is repeated and is unchanged from the prior visit.&nbsp; &#946;-hCG level is now 18,659 IU/L.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"1306\" src=\"https://www.uworld.com/media/highresdefault/L16818.jpg\"  ></p><p>This patient has a <strong>missed abortion</strong>, an intrauterine pregnancy demise at &lt;20 weeks gestation prior to expulsion of products of conception.&nbsp; Patients may be <strong>asymptomatic</strong> or have <strong>decreased pregnancy symptoms</strong> (eg, nausea, breast tenderness).&nbsp; Physical examination reveals a closed cervix.&nbsp; Risk factors for spontaneous abortion include advanced maternal age due to an associated increased risk for fetal chromosomal abnormalities.</p><p>Ultrasound findings in a missed abortion include either an <strong>embryo without cardiac activity</strong> or a persistently <strong>empty gestational sac</strong> without a fetal pole (eg, no embryo).&nbsp; Although some normal early pregnancies (&lt;6 weeks gestation) can present without a fetal pole (eg, gestational sac &plusmn; yolk sac), viability is determined through repeat ultrasounds and serial &#946;-hCG levels.&nbsp; Viable pregnancies have rising serial &#946;-hCG levels throughout the first trimester, and imaging reveals continued embryonic development (eg, fetal pole with cardiac activity).&nbsp; In contrast, a nonviable pregnancy has <strong>decreasing &#946;-hCG levels</strong>, and repeat imaging shows halted development.&nbsp; This patient has decreased &#946;-hCG levels, resolved pregnancy symptoms, and a repeat ultrasound with no further embryonic development (fetal pole), findings consistent with pregnancy demise <strong>(Choice D)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; A complete hydatidiform mole is an abnormal gestation that presents with heavy bleeding, a snowstorm appearance on ultrasound, and a markedly elevated &#946;-hCG level (&gt;100,000 IU/L).&nbsp; This patient&#39;s decreasing &#946;-hCG level makes a hydatidiform mole unlikely.</p><p><strong>(Choice B)</strong>&nbsp; An incomplete abortion presents with pain, bleeding, a dilated cervix, and passage of some products of conception.</p><p><strong>(Choice E)</strong>&nbsp; Threatened abortions present with bleeding and a closed cervix; ultrasound reveals an intrauterine gestation with a normal heartbeat.&nbsp; At 8 weeks gestation, threatened abortions would have increasing &#946;-hCG levels.</p><p><strong>Educational objective:</strong><br>A missed abortion is a pregnancy loss at &lt;20 weeks gestation prior to expulsion of products of conception.&nbsp; Patients with missed abortions are typically asymptomatic but can have symptoms of loss of pregnancy or light vaginal bleeding.&nbsp; Findings include a closed cervix, decreasing &#946;-hCG levels, and an ultrasound revealing a nonviable (eg, no fetal heartbeat) intrauterine pregnancy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 17495,
            "topic": "Abortion",
            "titleId": 17495,
            "title": "Abortion",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Complete hydatidiform mole",
                    "choiceNumber": 1,
                    "correctTaken": 4273,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Incomplete abortion",
                    "choiceNumber": 2,
                    "correctTaken": 2177,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Missed abortion",
                    "choiceNumber": 3,
                    "correctTaken": 8321,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal pregnancy",
                    "choiceNumber": 4,
                    "correctTaken": 884,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Threatened abortion",
                    "choiceNumber": 5,
                    "correctTaken": 1031,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "17304025",
                    "mediaDataId": 0,
                    "title": "Contemporary management of early pregnancy failure.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/17304025",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19879521",
                    "mediaDataId": 0,
                    "title": "Assessment and management of bleeding in the first trimester of pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19879521",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 148,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 16689,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 50,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 2,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 15745,
            "questionIndex": 17182,
            "questionText": "<p>A 29-year-old woman, gravida 1 para 0, at 33 weeks gestation is an inpatient on the antepartum unit for management of known vasa previa.&nbsp; A few minutes ago, the patient had rupture of membranes with leakage of blood-tinged fluid.&nbsp; She has no contractions or heavy vaginal bleeding.&nbsp; The pregnancy was the result of in vitro fertilization and has otherwise been uncomplicated.&nbsp; A fetal growth ultrasound performed yesterday revealed a cephalic fetus with an estimated fetal weight at the 50th percentile and a normal amniotic fluid index.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 110/70 mm Hg, and pulse is 70/min.&nbsp; Fetal heart rate is 100/min.&nbsp; The uterus is nontender and has no palpable contractions.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t53341\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Vasa previa</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>Fetal vessels overlying the cervix</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Placenta previa</li><li>Multiple gestations</li><li>In vitro fertilization</li><li>Succenturiate placental lobe</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Painless vaginal bleeding with ROM or contractions</li><li>FHR abnormalities (eg, bradycardia, sinusoidal pattern)</li><li>Fetal exsanguination &amp; demise</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Emergency cesarean delivery</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>FHR</strong> = fetal heart rate; <strong>ROM</strong> = rupture of membranes.</p></td></tr></tbody></table></div><p>Normal fetal vessels travel in the umbilical cord surrounded by thick, gelatinous tissue (ie, Wharton jelly) that protects them.&nbsp; In contrast, <strong>vasa previa</strong> is an <a href=\"28587\">aberrant condition</a> in which the <strong>fetal vessels overlie the cervix</strong>, surrounded only by thin fetal membranes, making them prone to <strong>tear</strong> with <strong>rupture of membranes</strong> or contractions.&nbsp; Risk factors include in vitro fertilization, as in this patient, and <a href=\"2778\">placenta previa</a>.</p><p>Vasa previa is typically diagnosed on fetal anatomy ultrasound at 18-20 weeks and managed with planned cesarean delivery at 34-35 weeks gestation (ie, prior to spontaneous labor).&nbsp; Because total fetal blood volume is low (eg, ~250 mL or 1 cup), even minimal fetal bleeding can lead to rapid <strong>exsanguination</strong> and <strong>fetal demise</strong>.&nbsp; Therefore, these patients require third-trimester inpatient management to monitor for acute changes that require immediate delivery.</p><p>This patient with vasa previa and rupture of membranes likely has a ruptured fetal vessel, as evidenced by the leakage of blood-tinged vaginal fluid and fetal bradycardia.&nbsp; This <strong>obstetric emergency</strong> requires immediate delivery.&nbsp; Because vaginal delivery can cause further fetal vessel tearing and fetal compromise, induction of labor is contraindicated <strong>(Choice D)</strong>.&nbsp; Therefore, the best next step in management is <strong>emergency cesarean delivery</strong>.</p><p><strong>(Choice A)</strong>&nbsp; In patients at risk for preterm delivery, betamethasone promotes fetal lung maturity and magnesium sulfate prevents neonatal seizures.&nbsp; Because betamethasone requires hours to take effect, it is not typically administered to patients requiring immediate delivery because it offers minimal benefit.&nbsp; In addition, magnesium sulfate is not administered to patients at &#8805;32 weeks gestation.</p><p><strong>(Choice B)</strong>&nbsp; A biophysical profile assesses for fetal hypoxia and asphyxia in high-risk patients to guide delivery timing.&nbsp; It does not change management of this patient who requires emergency cesarean delivery and may delay intervention, thereby risking fetal demise.</p><p><strong>(Choice E)</strong>&nbsp; Prophylactic latency antibiotics (eg, erythromycin, ampicillin) are indicated in patients at &lt;34 weeks gestation with preterm prelabor rupture of membranes to prevent fetal infection, delay delivery, and allow further fetal growth in utero.&nbsp; It is not indicated in patients requiring immediate delivery.</p><p><strong>Educational objective:</strong><br>Vasa previa is a rare condition in which the fetal vessels overlie the cervix, making them prone to tear and bleed with rupture of membranes or contractions.&nbsp; Management of a ruptured fetal vessel is with emergency cesarean delivery because of the high risk of fetal exsanguination and demise.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14133,
            "topic": "Antepartum bleeding",
            "titleId": 14133,
            "title": "Antepartum bleeding",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Betamethasone and magnesium sulfate",
                    "choiceNumber": 1,
                    "correctTaken": 995,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Biophysical profile",
                    "choiceNumber": 2,
                    "correctTaken": 528,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Emergency cesarean delivery",
                    "choiceNumber": 3,
                    "correctTaken": 2521,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Immediate induction of labor",
                    "choiceNumber": 4,
                    "correctTaken": 214,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prophylactic latency antibiotics",
                    "choiceNumber": 5,
                    "correctTaken": 681,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26694639",
                    "mediaDataId": 0,
                    "title": "Incidence of and risk indicators for vasa praevia: a systematic review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26694639",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21599804",
                    "mediaDataId": 0,
                    "title": "Prenatal diagnosis and management of vasa previa: a 6-year review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21599804",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19772710",
                    "mediaDataId": 0,
                    "title": "Guidelines for the management of vasa previa.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19772710",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 117,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 5017,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 50,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 15736,
            "questionIndex": 17173,
            "questionText": "<p>A 29-year-old primigravid woman at 30 weeks gestation comes to the office for evaluation of decreased fetal movement.&nbsp; The patient has had minimal fetal movement for the past few hours.&nbsp; She has had no vaginal bleeding or contractions.&nbsp; The patient has sickle cell disease and is taking low-dose aspirin.&nbsp; Her pregnancy is dated by a 10-week ultrasound, and she had a normal fetal anatomy ultrasound at 18 weeks gestation.&nbsp; At 24 weeks gestation, the patient had an abnormal glucose challenge test, but a normal glucose tolerance test.&nbsp; Blood pressure is 134/82 mm Hg and pulse is 90/min.&nbsp; BMI is 32 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Fetal heart rate is 140/min.&nbsp; Fundal height is 26 cm.&nbsp; Ultrasound reveals a cephalic male fetus measuring at the 16th percentile and an amniotic fluid index of 4 cm (normal: &gt;5 cm).&nbsp; Which of the following is the most likely cause of this patient&#39;s presentation?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t36765\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Sickle cell disease in pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Prenatal care</strong></p></td><td><ul><li>Baseline 24-hr urine collection/testing for total protein</li><li>Baseline chemistry panel</li><li>Serial urine cultures</li><li>Pneumococcal vaccination</li><li>Folic acid supplement</li><li>Aspirin</li><li>Serial fetal growth ultrasound examinations</li></ul></td></tr><tr><td><p align=\"center\"><strong>Obstetric complications</strong></p></td><td><ul><li>Spontaneous abortion</li><li>Preeclampsia, eclampsia</li><li>Abruptio placentae</li><li>Antepartum bleeding</li></ul></td></tr><tr><td><p align=\"center\"><strong>Fetal complications</strong></p></td><td><ul><li>Fetal growth restriction</li><li>Oligohydramnios</li><li>Preterm birth</li></ul></td></tr></tbody></table></div><p>Patients with <strong>sickle cell disease</strong> are at risk for multiple obstetric complications (eg, preeclampsia, fetal growth restriction) due to <strong>vasoocclusion</strong> that can result in placental infarction, ischemia, and subsequent <strong>uteroplacental insufficiency</strong>.</p><p>Adequate uteroplacental blood flow is essential for normal fetal development.&nbsp; Uteroplacental insufficiency results in <strong>decreased fetal perfusion</strong>, which limits fetal oxygenation and nutrition.&nbsp; In response, the fetus has decreased fetal movement, slowed growth (with possible fetal growth restriction), and preferential shunting of blood flow from the kidneys to the brain, as evidenced by decreased urine production and resultant <strong>oligohydramnios</strong> (ie, amniotic fluid index &#8804;5 cm).&nbsp; Oligohydramnios can present with a uterine size-less-than-dates discrepancy (eg, fundal height 26 cm at 30 weeks gestation), as in this patient.</p><p>Due to the high risk of intrauterine fetal demise associated with uteroplacental insufficiency, management is with close antenatal surveillance (eg, serial growth ultrasound, umbilical artery Doppler ultrasound) for monitoring of fetal well-being and delivery planning.</p><p><strong>(Choice A)</strong>&nbsp; Fetal congenital infections can cause decreased fetal movement and oligohydramnios; however, they typically present with additional ultrasound findings (eg, <a href=\"23610\">hydrops fetalis</a>, microcephaly).&nbsp; This patient&#39;s 18-week fetal anatomy ultrasound was normal, making this diagnosis less likely.</p><p><strong>(Choice B)</strong>&nbsp; Inaccurate pregnancy dating can cause a uterine size-dates discrepancy.&nbsp; However, first-trimester ultrasound is accurate within 7 days, making this an unlikely cause of this patient&#39;s presentation.</p><p><strong>(Choice C)</strong>&nbsp; Maternal obesity increases the risk of obstetric complications (eg, gestational diabetes, fetal macrosomia) that can cause a uterine size-greater-than-dates discrepancy.&nbsp; However, maternal obesity does not typically cause oligohydramnios (as often evidenced by a uterine size-less-than-dates discrepancy).</p><p><strong>(Choice D)</strong>&nbsp; Prepregnancy diabetes mellitus can cause chronic vascular disease leading to uteroplacental insufficiency, fetal growth restriction, and oligohydramnios.&nbsp; Gestational diabetes mellitus can cause fetal macrosomia and polyhydramnios (ie, amniotic fluid index &#8805;24 cm).&nbsp; However, pregnancy-induced hyperglycemia (eg, an abnormal glucose challenge test with a normal glucose tolerance test) does not cause significant changes.</p><p><strong>Educational objective:</strong><br>Maternal sickle cell disease causes vasoocclusion that can result in placental infarction, ischemia, and subsequent uteroplacental insufficiency.&nbsp; Uteroplacental insufficiency may present with decreased fetal movement and oligohydramnios (ie, amniotic fluid index &#8804;5 cm) due to decreased fetal perfusion.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 21778,
            "topic": "Oligohydramnios",
            "titleId": 21778,
            "title": "Oligohydramnios",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Fetal congenital infection",
                    "choiceNumber": 1,
                    "correctTaken": 595,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inaccurate pregnancy dating",
                    "choiceNumber": 2,
                    "correctTaken": 776,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal obesity",
                    "choiceNumber": 3,
                    "correctTaken": 1098,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pregnancy-induced hyperglycemia",
                    "choiceNumber": 4,
                    "correctTaken": 720,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uteroplacental insufficiency",
                    "choiceNumber": 5,
                    "correctTaken": 13382,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24866352",
                    "mediaDataId": 0,
                    "title": "Pregnancy in patients with sickle cell disease: maternal and perinatal outcomes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24866352",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22113135",
                    "mediaDataId": 0,
                    "title": "The obstetric management of sickle cell disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22113135",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20685550",
                    "mediaDataId": 0,
                    "title": "Sickle cell disease in pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20685550",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 77,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 16571,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 81,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 14442,
            "questionIndex": 15851,
            "questionText": "<p>A 33-year-old woman, gravida 1 para 0, at 39 weeks gestation comes to the hospital for a scheduled elective induction.&nbsp; She has had no contractions, vaginal bleeding, or leakage of fluid.&nbsp; Fetal movement is normal.&nbsp; Her pregnancy has been uncomplicated except for a positive group B <em>Streptococcus</em> (GBS) rectovaginal culture at 36 weeks gestation with resistance to erythromycin.&nbsp; The patient has no chronic medical conditions and has had no prior surgeries.&nbsp; She developed a nonpruritic maculopapular rash after taking penicillin in her 20s.&nbsp; Vital signs are normal.&nbsp; Abdomen is soft, gravid, and nontender.&nbsp; The cervix is 1 cm dilated and 60% effaced with the fetal vertex at -2 station.&nbsp; Fetal heart rate tracing is category 1.&nbsp; Given this patient&#39;s penicillin allergy, which of the following is the most appropriate pharmacotherapy for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33322\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Preventing neonatal group B <em>Streptococcus</em> infection</strong></p></td></tr><tr><td><p align=\"center\"><strong>Antenatal screening</strong></p></td><td><ul><li>Rectovaginal culture at 36-38 weeks gestation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Indications for intrapartum prophylaxis</strong></p></td><td><ul><li>GBS bacteriuria or GBS urinary tract infection in current pregnancy (regardless of treatment)</li><li>GBS-positive rectovaginal culture in current pregnancy</li><li>Unknown GBS status PLUS any of the following:<ul style=\"list-style-type:circle;\"><li>&lt;37 weeks gestation</li><li>Intrapartum fever</li><li>Rupture of membranes for &ge;18 hr</li></ul></li><li>Prior infant with early-onset neonatal GBS infection&nbsp;</li></ul></td></tr><tr><td><p align=\"center\"><strong>Intrapartum prophylaxis</strong></p></td><td><ul><li>Intravenous penicillin</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>GBS</strong> = group B <em>Streptococcus</em>.</p></td></tr></tbody></table></div><p>Antenatal screening for <strong>group B</strong> <em><strong>Streptococcus</strong></em> (GBS) is generally performed at 36-38 weeks gestation, and patients with a positive culture require <strong>intrapartum antibiotic prophylaxis</strong> (IAP) to prevent early-onset neonatal GBS infection <strong>(Choice C)</strong>.&nbsp; Intravenous penicillin and ampicillin are first-line agents because they reach high bactericidal concentrations in the amniotic fluid rapidly (eg, within 3-4 hours), have no fetal toxicity, and have a narrow spectrum of coverage, thereby minimizing bacterial resistance.</p><p>In patients with a <strong>penicillin allergy</strong>, IAP is chosen based on risk for anaphylaxis.&nbsp; This patient&#39;s prior nonpruritic maculopapular rash is considered <strong>low risk for anaphylaxis</strong>, but the same rash may recur if she is administered penicillin.&nbsp; Therefore, <strong>cefazolin</strong> (a first-generation cephalosporin) is the most appropriate pharmacotherapy for this patient.&nbsp; Cephalosporins have a lower risk of cross-reactivity but achieve the same high bactericidal concentrations in the amniotic fluid without fetal toxicity.</p><p><strong>(Choices B and E)</strong>&nbsp; In GBS-positive patients with a severe penicillin allergy (ie, reactions with a high risk for anaphylaxis, such as respiratory distress or urticaria), dual sensitivity testing of GBS isolates to both clindamycin and erythromycin is performed because erythromycin resistance is associated with inducible clindamycin resistance.&nbsp; In patients who are sensitive to both, IAP is with clindamycin.&nbsp; In patients who are resistant to clindamycin or erythromycin or for whom sensitivities are unavailable, IAP is with vancomycin.&nbsp; However, because vancomycin does not reach bactericidal concentrations in the amniotic fluid, infants of patients treated with vancomycin may require additional neonatal observation and evaluation.&nbsp; This patient with a penicillin allergy that is low risk for anaphylaxis can receive cefazolin.</p><p><strong>(Choice D)</strong>&nbsp; Nearly all GBS isolates have resistance to trimethoprim-sulfamethoxazole (TMP-SMX).&nbsp; In addition, TMP-SMX is avoided in the final month of pregnancy because it increases the risk of neonatal kernicterus.</p><p><strong>Educational objective:</strong><br>Pregnant patients positive for group B <em>Streptococcus</em> (GBS) receive intrapartum antibiotic prophylaxis to prevent early-onset neonatal GBS disease.&nbsp; Patients with a penicillin allergy that is low risk for anaphylaxis receive cefazolin.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 9953,
            "topic": "Group b streptococcal infection",
            "titleId": 9953,
            "title": "Group b streptococcal infection",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cefazolin",
                    "choiceNumber": 1,
                    "correctTaken": 8778,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Clindamycin",
                    "choiceNumber": 2,
                    "correctTaken": 4129,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No treatment indicated",
                    "choiceNumber": 3,
                    "correctTaken": 396,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Trimethoprim-sulfamethoxazole",
                    "choiceNumber": 4,
                    "correctTaken": 713,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vancomycin",
                    "choiceNumber": 5,
                    "correctTaken": 2673,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "634",
                    "mediaDataId": 0,
                    "title": "Maternal and neonatal group B Streptococcus infection",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21088663",
                    "mediaDataId": 0,
                    "title": "Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21088663",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 98,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 16689,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 53,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 14074,
            "questionIndex": 15477,
            "questionText": "<p>A 29-year-old woman, gravida 2 para 1, comes to the office at 20 weeks gestation for a routine obstetric examination.&nbsp; The patient has felt normal fetal movement and has had no contractions, vaginal bleeding, or pelvic pain.&nbsp; She had diet-controlled gestational diabetes mellitus during her first pregnancy and underwent a cesarean delivery at 36 weeks gestation for preterm labor complicated by breech presentation.&nbsp; The patient has chronic hypertension, currently requiring 2 antihypertensive medications.&nbsp; She had a copper-releasing intrauterine device, placed after her first delivery, that was removed last year to try for pregnancy.&nbsp; The patient does not use tobacco, alcohol, or illicit drugs.&nbsp; Blood pressure is 144/96 mm Hg.&nbsp; BMI is 38 kg/m&sup2;.&nbsp; Ultrasound shows a single cephalic fetus at the 40th percentile for growth.&nbsp; Cervical length is 4.4 cm and a posterior placenta extends over the cervix.&nbsp; Amniotic fluid index measures 18 cm.&nbsp; Which of the following is the greatest risk factor for this patient&#39;s ultrasound findings?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"19273\" src=\"https://www.uworld.com/media/L44156.jpg\" ></p><p>This patient has <strong>placenta previa</strong>, in which the placenta <strong>extends over and covers the cervix</strong>.&nbsp; Most patients are <strong>asymptomatic</strong> and are <strong>incidentally diagnosed</strong> on second-trimester ultrasound (as in this patient).&nbsp; Patients with placenta previa require pelvic rest (no intercourse or digital cervical examination) because minimal cervical manipulation can cause cervical changes (eg, shortening, dilation) that can result in partial placental detachment and massive maternal hemorrhage.</p><p>Placenta previa can occur in any pregnancy; however, this patient&#39;s <strong>major risk factor</strong> is her <strong>prior cesarean delivery</strong>.&nbsp; Increasing cesarean delivery rates have caused an increased incidence of placenta previa because the uterine scar and change in vascularity likely alter early pregnancy implantation.&nbsp; Additional risk factors include <strong>prior placenta previa</strong>, <strong>multiple gestation</strong> (ie, increased placental surface area), and <strong>advanced maternal age</strong> (age &#8805;35) <strong>(Choice C)</strong>.&nbsp; Most cases resolve spontaneously by the third trimester due to physiologic lower uterine segment lengthening and/or placental growth toward the fundus.&nbsp; Patients with persistent previa undergo cesarean delivery at 36-37 weeks gestation (ie, prior to the onset of labor).</p><p><strong>(Choice A)</strong>&nbsp; Obesity in pregnancy (ie, prepregnancy BMI &#8805;30 kg/m&sup2;) increases risks of fetal demise and fetal macrosomia (&gt;90th percentile), which are not seen in this patient.</p><p><strong>(Choice B)</strong>&nbsp; Pregnancy complicated by chronic hypertension confers an elevated risk of fetal growth restriction (&lt;10th percentile) and oligohydramnios (amniotic fluid index [AFI] &#8804;5 cm) due to uteroplacental insufficiency.&nbsp; This patient has a normal estimated fetal weight and AFI.</p><p><strong>(Choice E)</strong>&nbsp; Prior gestational diabetes mellitus increases the risk for recurrent gestational and future type 2 diabetes mellitus.&nbsp; Diabetes mellitus in pregnancy increases the risk for fetal macrosomia (&gt;90th percentile) and polyhydramnios (AFI &#8805;24 cm), which are not seen in this patient.</p><p><strong>(Choice F)</strong>&nbsp; Prior preterm birth increases the risk for recurrent preterm birth, typically at similar gestational ages.&nbsp; Patients at risk for preterm birth often have shortened cervical lengths (eg, &#8804;2.5 cm).&nbsp; This patient&#39;s cervical length is normal.</p><p><strong>(Choice G)</strong>&nbsp; Although pregnancy complicated by current intrauterine device use has an elevated risk of ectopic pregnancy, spontaneous abortion, and intra-amniotic infection, prior intrauterine device use is not associated with obstetric complications.</p><p><strong>Educational objective:</strong><br>Placenta previa occurs when the placenta extends over and covers the cervix and is typically diagnosed incidentally on ultrasound.&nbsp; Prior cesarean delivery is a major risk factor for placenta previa, and persistent cases are managed with cesarean delivery at 36-37 weeks gestation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14133,
            "topic": "Antepartum bleeding",
            "titleId": 14133,
            "title": "Antepartum bleeding",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "BMI",
                    "choiceNumber": 1,
                    "correctTaken": 869,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chronic hypertension",
                    "choiceNumber": 2,
                    "correctTaken": 3515,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal age",
                    "choiceNumber": 3,
                    "correctTaken": 124,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prior cesarean delivery",
                    "choiceNumber": 4,
                    "correctTaken": 10011,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prior gestational diabetes mellitus",
                    "choiceNumber": 5,
                    "correctTaken": 901,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prior preterm birth",
                    "choiceNumber": 6,
                    "correctTaken": 1066,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recent intrauterine device use",
                    "choiceNumber": 7,
                    "correctTaken": 288,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29913334",
                    "mediaDataId": 0,
                    "title": "Abnormal placentation: current evidence and review of the literature.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29913334",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26428505",
                    "mediaDataId": 0,
                    "title": "Using ultrasound in the clinical management of placental implantation abnormalities.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26428505",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29079144",
                    "mediaDataId": 0,
                    "title": "Society for Maternal-Fetal Medicine (SMFM) consult series #44: management of bleeding in the late preterm period.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29079144",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 142,
            "othersAvgTimeSpent": 75,
            "notes": null,
            "peopleTaken": 16774,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 14811,
            "questionIndex": 16234,
            "questionText": "<p>A 34-year-old woman, gravida 2 para 1, at 26 weeks gestation comes to the emergency department due to intermittent leakage of fluid for the past 6 hours.&nbsp; She has had no vaginal bleeding or contractions.&nbsp; The patient&#39;s previous pregnancy was complicated by preterm prelabor rupture of membranes at 29 weeks gestation; she delivered at 34 weeks gestation after inpatient management with corticosteroids and latency antibiotics.&nbsp; Temperature is 39.4 C (103 F), blood pressure is 100/70 mm Hg, and pulse is 114/min.&nbsp; Fetal heart rate is 170/min.&nbsp; The uterus is tender to palpation.&nbsp; On speculum examination, purulent amniotic fluid emerges from the cervix with Valsalva and turns the nitrazine paper blue.&nbsp; The cervix is visibly closed.&nbsp; Transabdominal ultrasound shows a vertex fetus consistent with gestational age.&nbsp; The amniotic fluid index is 8 cm.&nbsp; In addition to antibiotics, which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t36642\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Intraamniotic infection (chorioamnionitis)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Prolonged rupture of membranes (&gt;18 hr)</li><li>Preterm prelabor rupture of membranes</li><li>Prolonged labor</li><li>Internal fetal/uterine monitoring devices</li><li>Repetitive vaginal examinations</li><li>Presence of genital tract pathogens</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><p>Maternal fever PLUS &ge;1 of the following:</p><ul><li>Fetal tachycardia (&gt;160/min)</li><li>Maternal leukocytosis</li><li>Purulent amniotic fluid</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Broad-spectrum antibiotics</li><li>Delivery</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Maternal: postpartum hemorrhage, endometritis</li><li>Neonatal: preterm birth, pneumonia, encephalopathy</li></ul></td></tr></tbody></table></div><p>This patient at 26 weeks gestation has <strong>preterm prelabor rupture of membranes (PPROM)</strong> based on leakage of nitrazine-positive fluid (ie, alkaline amniotic fluid) emerging from the cervix.&nbsp; Risk factors for PPROM include prior PPROM (as in this patient), genitourinary infection, and antepartum bleeding.&nbsp; Uncomplicated cases of PPROM are managed expectantly with inpatient monitoring (eg, serial fetal ultrasounds), prophylactic latency antibiotics, corticosteroids, and delivery at 34 weeks gestation <strong>(Choices B, D, and E)</strong>.</p><p>However, patients who develop complications (eg, placental abruption, cord prolapse) do not meet criteria for expectant management.&nbsp; This patient has <strong>fever</strong> and <strong>fetal tachycardia</strong> consistent with an <strong>intraamniotic infection (IAI)</strong> (ie, chorioamnionitis), a fulminant polymicrobial infection of the amniotic sac, fetus, cord, and placenta from ascending vaginal flora.&nbsp; Additional signs may include maternal tachycardia, <strong>uterine tenderness</strong>, and malodorous or <strong>purulent amniotic fluid</strong>.&nbsp; IAI has an increased risk of maternal morbidity (eg, sepsis, disseminated intravascular coagulation) and mortality that outweighs the fetal benefit gained by prolonging pregnancy.&nbsp; Therefore, patients with PPROM complicated by&nbsp;IAI require <strong>therapeutic antibiotics and immediate delivery</strong> (eg, induction of labor), regardless of gestational age.</p><p><strong>(Choice A)</strong>&nbsp; Fetal fibronectin is used to identify patients with preterm contractions who are at high risk for preterm delivery.&nbsp; It is not performed in PPROM because the risk of preterm delivery is high and, therefore, does not change management.&nbsp; Fetal lung maturity testing is performed in patients with uncertain gestational dating to determine timing of delivery (ie, prolong pregnancy for fetal benefit).&nbsp; Neither of these tests is indicated because this patient requires immediate delivery.</p><p><strong>Educational objective:</strong><br>Intraamniotic infection (chorioamnionitis) is a complication of preterm prelabor rupture of membranes.&nbsp; Due to the increased risk of maternal morbidity and mortality, patients with intraamniotic infection require therapeutic antibiotics and immediate delivery, regardless of gestational age.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23687,
            "topic": "Preterm premature rupture of the membranes",
            "titleId": 23687,
            "title": "Preterm premature rupture of the membranes",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Fetal fibronectin and lung maturity testing",
                    "choiceNumber": 1,
                    "correctTaken": 3923,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Expectant management",
                    "choiceNumber": 2,
                    "correctTaken": 2029,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Immediate induction of labor",
                    "choiceNumber": 3,
                    "correctTaken": 7550,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Outpatient monitoring and bed rest",
                    "choiceNumber": 4,
                    "correctTaken": 500,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serial fetal ultrasounds and amnioinfusion",
                    "choiceNumber": 5,
                    "correctTaken": 2687,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "2035575",
                    "mediaDataId": 0,
                    "title": "Progress in pathogenesis and management of clinical intraamniotic infection.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/2035575",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "15329560",
                    "mediaDataId": 0,
                    "title": "An evidence-based approach to the evaluation and treatment of premature rupture of membranes: part I.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/15329560",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 155,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 16689,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 45,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 2532,
            "questionIndex": 2532,
            "questionText": "<p>A 32-year-old woman, gravida 3 para 2, at 38 weeks gestation comes to the hospital due to contractions.&nbsp; The patient&#39;s prenatal course has been uncomplicated.&nbsp; She had a cesarean delivery for breech presentation at 39 weeks gestation in her second pregnancy.&nbsp; Blood pressure is 100/60 mm Hg, pulse is 100/min, and respirations are 22/min.&nbsp; Fetal heart rate tracing shows moderate variability, multiple accelerations, and no decelerations.&nbsp; Uterine contractions are regular and occur every 4 minutes.&nbsp; The cervix is 6 cm dilated and 60% effaced, and the fetal vertex is at 0 station.&nbsp; After 2 hours, the patient is suddenly restless and has intense lower abdominal pain.&nbsp; Fetal heart monitoring shows recurrent late decelerations.&nbsp; On pelvic examination, there is moderate vaginal bleeding, the cervix is 6 cm dilated and 60% effaced, and the fetal vertex is at &#8722;3 station.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"28624\" src=\"https://www.uworld.com/media/L54679.jpg\" ></p><p>This patient with restlessness and intense, sudden-onset lower abdominal pain most likely has <strong>uterine rupture</strong>, a disruption of the uterine wall typically associated with contractions.&nbsp; Uterine rupture usually occurs in patients with <strong>prior uterine surgery</strong> (eg, cesarean delivery, myomectomy) because weakened uterine scar tissue can separate with the force of contractions.&nbsp; Patients can develop massive <strong>bleeding</strong> (ie, intraabdominal, vaginal) due to the highly vascular pregnant uterus.</p><p>When the uterus ruptures, the sudden decrease in intrauterine pressure and partial fetal delivery into the maternal abdomen can result in <strong>loss of fetal station</strong> (eg, 0 to &#8722;3 station).&nbsp; Fetal parts may also become palpable abdominally (ie, an irregular protuberance).&nbsp; Patients typically develop an <strong>abnormal fetal heart rate tracing</strong>, including recurrent variable and late decelerations caused by umbilical cord compression and reduced uteroplacental blood flow, respectively.&nbsp; To prevent further maternal and fetal compromise, management includes emergency laparotomy and cesarean delivery.</p><p><strong>(Choice A)</strong>&nbsp; <a href=\"1113\">Abruptio placentae</a>, the premature separation of the placenta from the uterus, can present with vaginal bleeding, abdominal pain, and an abnormal fetal heart rate tracing.&nbsp; However, it is not associated with loss of fetal station.</p><p><strong>(Choice B)</strong>&nbsp; A fetal nuchal cord, a loop of umbilical cord around the fetal neck, is a common incidental finding that may cause cord compression (eg, recurrent variable decelerations) during labor.&nbsp; However, it does not cause abdominal pain, vaginal bleeding, or late decelerations.</p><p><strong>(Choice C)</strong>&nbsp; Normal labor typically presents with painful contractions and light vaginal bleeding from cervical dilation.&nbsp; However, in normal labor, the presenting fetal part descends (eg, 0 to +2 station) with advancing dilation.</p><p><strong>(Choice E)</strong>&nbsp; <a href=\"28587\">Vasa previa</a>, or fetal vessels overlying the cervix, is prone to tearing and can cause vaginal bleeding with an abnormal fetal heart rate tracing due to fetal blood loss.&nbsp; However, there is no associated abdominal pain or loss of fetal station, making this diagnosis unlikely.</p><p><strong>Educational objective:</strong><br>Patients with prior uterine surgery (eg, cesarean delivery) are at increased risk for uterine rupture, a disruption of the uterine wall typically associated with contractions.&nbsp; Uterine rupture may present with intense abdominal pain, vaginal bleeding, fetal heart rate tracing abnormalities, and loss of fetal station.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14133,
            "topic": "Antepartum bleeding",
            "titleId": 14133,
            "title": "Antepartum bleeding",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Abruptio placentae",
                    "choiceNumber": 1,
                    "correctTaken": 4310,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal nuchal cord",
                    "choiceNumber": 2,
                    "correctTaken": 579,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal labor",
                    "choiceNumber": 3,
                    "correctTaken": 374,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine rupture",
                    "choiceNumber": 4,
                    "correctTaken": 10814,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vasa previa",
                    "choiceNumber": 5,
                    "correctTaken": 603,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30681543",
                    "mediaDataId": 0,
                    "title": "ACOG practice bulletin no. 205: vaginal birth after cesarean delivery.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30681543",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 80,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 16682,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 15069,
            "questionIndex": 16493,
            "questionText": "<p>A 27-year-old woman, gravida 1 para 0, comes to the office for an initial prenatal visit.&nbsp; The patient is uncertain when her last menstrual period occurred, but she has had daily nausea and vomiting for the last 2 months.&nbsp; She has had no vaginal bleeding or pelvic pain.&nbsp; The patient has no chronic medical conditions and has had no surgeries.&nbsp; She takes a daily prenatal vitamin.&nbsp; Vital signs are normal.&nbsp; Abdominal examination reveals a gravid uterus that is nontender, and the fundus is just below the umbilicus.&nbsp; Ultrasound shows 2 intrauterine fetal poles measuring 14 weeks gestation with heart rates of 150/min and 155/min.&nbsp; Cervical length is 4.5 cm (normal: &gt;2.5).&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32393\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Preeclampsia prevention</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>New-onset hypertension &amp; proteinuria &amp;/or<br />end-organ damage at &gt;20 weeks gestation</li></ul></td></tr><tr><td><p align=\"center\"><strong>High risk </strong></p></td><td><ul><li>Prior preeclampsia</li><li>Chronic kidney disease</li><li>Chronic hypertension</li><li>Diabetes mellitus</li><li>Multiple gestation</li><li>Autoimmune disease</li></ul></td></tr><tr><td><p align=\"center\"><strong>Moderate risk</strong></p></td><td><ul><li>Obesity</li><li>Advanced maternal age</li><li>Nulliparity</li></ul></td></tr><tr><td><p align=\"center\"><strong>Prevention</strong></p></td><td><ul><li>Low-dose aspirin at 12 weeks gestation</li></ul></td></tr></tbody></table></div><p>Patients with certain predisposing factors, such as diabetes mellitus, chronic hypertension, and <strong>multiple gestations</strong>, are at <strong>high risk</strong> for preeclampsia, a leading cause of maternal and fetal morbidity and mortality (eg, risk for stroke, placental abruption, disseminated intravascular coagulation).&nbsp; <strong>Preeclampsia</strong> likely results from abnormal vasoconstriction and increased platelet aggregation, leading to placental infarction and ischemia.&nbsp; Twin gestation, as in this patient, increases the risk nearly threefold, possibly due to greater placental mass and, subsequently, a higher risk for placental hypoperfusion leading to placental ischemia.</p><p>In <strong>high-risk patients</strong>, daily <strong>low-dose aspirin</strong> is the only proven therapy to <strong>decrease the risk </strong>for preeclampsia because it inhibits platelet aggregation and helps prevent placental ischemia.&nbsp; It is initiated at 12-28 weeks gestation (but optimally before 16 weeks) and continued daily until delivery.</p><p><strong>(Choice A)</strong>&nbsp; Cerclage placement decreases the risk for preterm delivery in patients with a short cervix (&#8804;2.5 cm) on ultrasound or a prior preterm delivery caused by cervical insufficiency (ie, painless cervical dilation).&nbsp; This patient&#39;s cervical length is normal, and this is her first pregnancy (ie, no prior preterm deliveries).</p><p><strong>(Choice B)</strong>&nbsp; Indomethacin is a tocolytic used in patients in preterm labor at &lt;32 weeks gestation to halt contractions and delay labor.&nbsp; It is not used as a prophylactic medication to prevent preterm labor.</p><p><strong>(Choice D)</strong>&nbsp; Low-molecular-weight heparin can be used for venous thromboembolism (VTE) prophylaxis in patients with a prior VTE or a hypercoagulable condition (eg, certain inherited thrombophilias, antiphospholipid syndrome).&nbsp; It is not required for patients with multiple gestations.</p><p><strong>(Choice E)</strong>&nbsp; Progesterone therapy (eg, intramuscular, vaginal) is offered to patients with a prior spontaneous preterm delivery or with a short cervix (ie, &#8804;2.5 cm) diagnosed incidentally on transvaginal ultrasound because it may decrease the risk for recurrence.&nbsp; This patient has not had a prior spontaneous preterm delivery, and her cervical length is normal.&nbsp; Although multiple gestations are at increased risk for preterm delivery, progesterone therapy is not routinely recommended in case of multiple gestations and does not improve outcomes in patients without a prior preterm birth.</p><p><strong>Educational objective:</strong><br>Patients at high risk for preeclampsia (eg, multiple gestations) are prescribed low-dose aspirin prophylaxis at 12-28 weeks gestation (but optimally before 16 weeks) for prevention.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4219,
            "topic": "Preeclampsia",
            "titleId": 4219,
            "title": "Preeclampsia",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cerclage placement",
                    "choiceNumber": 1,
                    "correctTaken": 1607,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Indomethacin",
                    "choiceNumber": 2,
                    "correctTaken": 697,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Low-dose aspirin",
                    "choiceNumber": 3,
                    "correctTaken": 9250,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Low-molecular-weight heparin",
                    "choiceNumber": 4,
                    "correctTaken": 797,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Progesterone therapy",
                    "choiceNumber": 5,
                    "correctTaken": 4284,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31278106",
                    "mediaDataId": 0,
                    "title": "Prevalence and risk of pre-eclampsia and gestational hypertension in twin pregnancies: a population-based register study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31278106",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29939936",
                    "mediaDataId": 0,
                    "title": "ACOG committee opinion no. 743 summary: low-dose aspirin use during pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29939936",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28317207",
                    "mediaDataId": 0,
                    "title": "Hidden high rate of pre-eclampsia in twin compared with singleton pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28317207",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24711050",
                    "mediaDataId": 0,
                    "title": "Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24711050",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 47,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 16635,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 11162,
            "questionIndex": 12312,
            "questionText": "<p>A 15-year-old girl is brought to the emergency department due to a severe headache, abdominal pain, nausea, and vomiting.&nbsp; The patient reports an occipital headache that began 4 days ago and has increased in severity despite treatment with acetaminophen.&nbsp; The nausea and vomiting began a day ago, and now the patient is unable to tolerate liquids.&nbsp; The abdominal pain is constant but worsens with vomiting.&nbsp; She has no chills, photophobia, or dizziness.&nbsp; The patient is sexually active.&nbsp; Her last menstrual period was 4 months ago.&nbsp; She does not use tobacco, alcohol, or recreational drugs.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 150/90 mm Hg, and pulse is 90/min.&nbsp; Cardiopulmonary examination is normal.&nbsp; Abdominal examination shows right upper quadrant tenderness without rebound or rigidity.&nbsp; There is a nontender, palpable abdominal mass that extends from the pubic symphysis up to the umbilicus.&nbsp; Neurologic examination shows intact cranial nerves, no nystagmus, and no pain with neck flexion.&nbsp; Bilateral lower extremities have 3+ deep tendon reflexes at the patella and sustained ankle clonus.&nbsp; Serum &#946;-hCG is elevated.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T31152\" style=\"overflow-x:auto;\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hydatidiform mole</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Abnormal vaginal bleeding &plusmn; hydropic tissue</li><li>Uterine enlargement &gt; gestational age</li><li>Abnormally elevated &#946;-hCG levels</li><li>Theca lutein ovarian cysts</li><li>Hyperemesis gravidarum</li><li>Preeclampsia with severe features&nbsp;</li><li>Hyperthyroidism</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Extremes of maternal age</li><li>History of hydatidiform mole</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>&#x22;Snowstorm&#x22; appearance on ultrasound</li><li>Quantitative serum &#946;-hCG</li><li>Histologic evaluation of uterine contents</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Dilation &amp; suction curettage</li><li>Serial serum &#946;-hCG post evacuation</li><li>Contraception for 6 months</li></ul></td></tr></tbody></table></div><p>This patient&#39;s new-onset <strong>hypertension</strong>, <strong>hyperreflexia</strong> (eg, clonus), and elevated &#946;-hCG levels are concerning for preeclampsia.&nbsp; Headache and right upper quadrant pain (due to hepatic swelling and stretching of the Glisson capsule) are additional signs of end-organ damage indicating severe features.&nbsp; Preeclampsia with severe features is unusual at &lt;20 weeks gestation (ie, typically presents in the late third trimester).&nbsp; Therefore, patients with signs and symptoms of early <strong>preeclampsia at &lt;20 weeks</strong> gestation require evaluation for an <strong>abnormal pregnancy</strong> such as a <strong>hydatidiform mole (HM)</strong>.</p><p>HM, a type of gestational trophoblastic disease, is a nonviable gestation composed of abnormal placental tissue (eg, hyperplastic trophoblasts, hydropic trophoblastic villi).&nbsp; Extremes of maternal age are risk factors.&nbsp; Early-onset preeclampsia in HM is likely due to rapid and <strong>excessive trophoblast proliferation</strong> followed by abnormal spiral artery development, which causes placental hypoperfusion, placental ischemia, and hypertension.&nbsp; Abnormal trophoblast proliferation also leads to <strong>markedly elevated &#946;-hCG levels</strong> (which, in turn, can induce severe nausea/vomiting) and an <strong>enlarged uterus</strong> (eg, up to the umbilicus) that is larger than expected for gestational age.</p><p>Diagnosis is confirmed on pelvic ultrasonography showing the uterus filled with a heterogeneous mass of <a href=\"3116\">anechoic, cystic spaces</a> (eg, &#x22;snowstorm&#x22; appearance).&nbsp; Treatment of HM is uterine evacuation (eg, <strong>suction curettage</strong>) to remove the trophoblastic tissue, after which the preeclampsia resolves.</p><p><strong>(Choice A)</strong>&nbsp; Cholecystitis can present with right upper quadrant pain, nausea, and vomiting.&nbsp; However, cholecystitis is uncommon in adolescents and is not associated with hypertension, neurologic findings, or a pelvic mass.</p><p><strong>(Choice B)</strong>&nbsp; Embryonal carcinoma, an aggressive ovarian cancer typically diagnosed in adolescents, can present with an abdominal mass and elevated &#946;-hCG level.&nbsp; Patients typically have ascites rather than hypertension or neurologic symptoms.</p><p><strong>(Choice C)</strong>&nbsp; Fitz&ndash;Hugh&ndash;Curtis syndrome (eg, perihepatitis) is a sequela of pelvic inflammatory disease that causes pleuritic right upper quadrant pain.&nbsp; However, patients typically have associated fever and hypotension (eg, sepsis) rather than hypertension and an abdominal mass.</p><p><strong>(Choice E)</strong>&nbsp; Viral encephalitis can present with headache and hyperreflexia.&nbsp; This patient does not have fever, photophobia, or cranial nerve deficits, making this diagnosis unlikely.</p><p><strong>Educational objective:</strong><br>Hydatidiform mole is a nonviable pregnancy characterized by excessive trophoblast proliferation.&nbsp; It can present with elevated &#946;-hCG levels, an enlarged uterus, and preeclampsia with severe features at &lt;20 weeks gestation.&nbsp; The preeclampsia resolves after treatment of the hydatidiform mole (eg, suction curettage).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 18244,
            "topic": "Gestational trophoblastic disease",
            "titleId": 18244,
            "title": "Gestational trophoblastic disease",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute cholecystitis",
                    "choiceNumber": 1,
                    "correctTaken": 513,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Embryonal carcinoma",
                    "choiceNumber": 2,
                    "correctTaken": 436,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fitz&ndash;Hugh&ndash;Curtis syndrome",
                    "choiceNumber": 3,
                    "correctTaken": 2040,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hydatidiform mole",
                    "choiceNumber": 4,
                    "correctTaken": 2123,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Viral encephalitis",
                    "choiceNumber": 5,
                    "correctTaken": 75,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27577709",
                    "mediaDataId": 0,
                    "title": "Trophoblastic debris extruded from hydatidiform molar placentae activates endothelial cells: possible relevance to the pathogenesis of preeclampsia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27577709",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 122,
            "othersAvgTimeSpent": 81,
            "notes": null,
            "peopleTaken": 5187,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 41,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 31,
            "questionId": 11037,
            "questionIndex": 12177,
            "questionText": "<p>A 32-year-old woman, gravida 5 para 1 aborta 3, at 37 weeks gestation comes to the hospital due to rupture of membranes and contractions over the past hour.&nbsp; The patient is tolerating her contractions well.&nbsp; She has had 3 prior miscarriages, and her most recent pregnancy ended at 29 weeks gestation due to preeclampsia with severe features.&nbsp; The current pregnancy has been complicated by diet-controlled gestational diabetes mellitus and asymptomatic group B <em>Streptococcus</em> bacteriuria.&nbsp; Blood pressure is 134/86 mm Hg, and pulse is 98/min.&nbsp; The uterus is nontender and has palpable contractions.&nbsp; Fetal heart rate tracing is category 1.&nbsp; The cervix is 5 cm dilated and 80% effaced, with the fetal vertex at &#8722;1 station.&nbsp; Blood glucose is 110 mg/dL.&nbsp; Which of the following additional therapy is indicated at this time?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33322\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Preventing neonatal group B <em>Streptococcus</em> infection</strong></p></td></tr><tr><td><p align=\"center\"><strong>Antenatal screening</strong></p></td><td><ul><li>Rectovaginal culture at 36-38 weeks gestation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Indications for intrapartum prophylaxis</strong></p></td><td><ul><li>GBS bacteriuria or GBS urinary tract infection in current pregnancy (regardless of treatment)</li><li>GBS-positive rectovaginal culture in current pregnancy</li><li>Unknown GBS status PLUS any of the following:<ul style=\"list-style-type:circle;\"><li>&lt;37 weeks gestation</li><li>Intrapartum fever</li><li>Rupture of membranes for &ge;18 hr</li></ul></li><li>Prior infant with early-onset neonatal GBS infection&nbsp;</li></ul></td></tr><tr><td><p align=\"center\"><strong>Intrapartum prophylaxis</strong></p></td><td><ul><li>Intravenous penicillin</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>GBS</strong> = group B <em>Streptococcus</em>.</p></td></tr></tbody></table></div><p><strong>Group B</strong>&nbsp;<em><strong>Streptococcus</strong></em>&nbsp;<strong>(GBS)</strong> is a common colonizer of the gastrointestinal and genital tracts.&nbsp; GBS is typically asymptomatic in pregnant patients, but it can be vertically transmitted to the neonate during vaginal delivery or with rupture of membranes, resulting in <strong>early-onset neonatal infection</strong> (eg, sepsis, pneumonia).&nbsp; To decrease the risk of vertical transmission, most women are screened at 36-38 weeks gestation by rectovaginal culture and administered intrapartum antibiotic prophylaxis if they are GBS-positive.</p><p>However, some women do not undergo GBS screening because they are considered to have <strong>persistent, heavy GBS colonization</strong> (ie, a high bacterial load) and therefore they are at <strong>increased risk for vertical transmission</strong>.&nbsp; Markers of heavy maternal colonization include <strong>GBS asymptomatic bacteriuria</strong> (as in this patient) or <strong>GBS urinary tract infection</strong> during the current pregnancy (regardless of treatment).&nbsp; Another marker of heavy maternal GBS colonization is prior delivery of an infant with early-onset neonatal infection (which is typically due to GBS).&nbsp; These women with heavy GBS colonization require <strong>intrapartum antibiotic prophylaxis</strong> (eg, penicillin) regardless of screening status or rectovaginal culture results <strong>(Choice D)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Betamethasone is administered to patients at risk for preterm delivery (&lt;37 weeks gestation) to promote fetal lung maturity and decrease the risk of neonatal respiratory distress syndrome.</p><p><strong>(Choice B)</strong>&nbsp; Women with either insulin-dependent gestational or prepregnancy diabetes mellitus require frequent glucose monitoring during labor and possible insulin administration for maternal blood glucose control.&nbsp; In contrast, patients with diet-controlled gestational diabetes mellitus do not have severe blood glucose fluctuations (as seen in this patient&#39;s normal glucose level); therefore, these patients do not require intrapartum glucose monitoring or insulin.</p><p><strong>(Choice C)</strong>&nbsp; Patients who have preeclampsia with severe features (eg, severe hypertension, headaches, scotomata) are at risk for eclampsia and require magnesium sulfate for seizure prophylaxis.&nbsp; This patient&#39;s blood pressure is normal.</p><p><strong>Educational objective:</strong><br>Patients with group B <em>Streptococcus</em> (GBS) asymptomatic bacteriuria or urinary tract infection in their current pregnancy (regardless of treatment) are heavily colonized with GBS and at high risk for vertical transmission to the neonate (ie, early-onset neonatal infection).&nbsp; These patients require intrapartum GBS prophylaxis (eg, penicillin) and do not require GBS screening.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 9953,
            "topic": "Group b streptococcal infection",
            "titleId": 9953,
            "title": "Group b streptococcal infection",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Betamethasone",
                    "choiceNumber": 1,
                    "correctTaken": 380,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Insulin",
                    "choiceNumber": 2,
                    "correctTaken": 138,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Magnesium sulfate",
                    "choiceNumber": 3,
                    "correctTaken": 465,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional therapy",
                    "choiceNumber": 4,
                    "correctTaken": 1163,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Penicillin",
                    "choiceNumber": 5,
                    "correctTaken": 14552,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24084566",
                    "mediaDataId": 0,
                    "title": "Practice bulletins no. 139: premature rupture of membranes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24084566",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21088663",
                    "mediaDataId": 0,
                    "title": "Prevention of perinatal group B streptococcal diseaserevised guidelines from CDC, 2010.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21088663",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 77,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 16698,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 87,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 32,
            "questionId": 12781,
            "questionIndex": 14077,
            "questionText": "<p>A 26-year-old woman, gravida 3 para 0 aborta 2, at 34 weeks gestation comes to the emergency department due to decreased fetal movement for the past day.&nbsp; The patient has had no contractions, vaginal bleeding, or leakage of fluid.&nbsp; She has had no prenatal care this pregnancy because she moved to a different state for a new job.&nbsp; The patient&#39;s first 2 pregnancies ended in miscarriages at 8 weeks gestation, and her current pregnancy is with a new partner.&nbsp; She has no chronic medical conditions, and her only medication is a prenatal vitamin.&nbsp; BMI is 28 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Temperature is 37.5 C (99.5 F), blood pressure is 134/88 mm Hg, and pulse is 98/min.&nbsp; Fundal height is 30 cm.&nbsp; There is 1+ bilateral pedal edema.&nbsp; Fetal heart tones are not auscultated.&nbsp; Ultrasonography reveals a singleton fetus with normal anatomy but no cardiac activity.&nbsp; Biparietal diameter and head circumference measure at 34 weeks gestation, and femur length and abdominal circumference measure at 30 and 28 weeks, respectively.&nbsp; The placenta is anterior, and the amniotic fluid index is 4 cm (normal: 5-24).&nbsp; Complete blood count is normal and maternal blood type is O positive.&nbsp; Which of the following is the most likely underlying cause of this patient&#39;s fetal demise?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T35373\"><table class=\"table-default-style\" style=\"width:468px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Diagnostic criteria for antiphospholipid-antibody syndrome</strong></p><p align=\"center\"><strong>(1 clinical &amp; 1 laboratory criterion must be met)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical</strong></p></td><td><p><strong>Vascular thrombosis</strong></p><ul><li>Arterial or venous</li></ul><p><strong>Pregnancy morbidity</strong></p><ul><li>&#8805;3 consecutive, unexplained fetal losses before 10th week</li><li>&#8805;1 unexplained fetal losses after 10th week</li><li>&#8805;1 premature births of normal neonates before 34th week due to preeclampsia, eclampsia, or placental insufficiency</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory</strong></p></td><td><ul><li>Lupus anticoagulant</li><li>Anticardiolipin antibody</li><li>Anti&ndash;beta-2 glycoprotein antibody I</li></ul></td></tr></tbody></table></div><p>This patient at 34 weeks gestation has had an intrauterine fetal demise, or <strong>stillbirth</strong>.&nbsp; The underlying cause may be fetal, placental, or maternal.&nbsp; Therefore, evaluation includes fetal studies (eg, autopsy, karyotyping), gross and microscopic examination of the placenta, and maternal testing guided by patient history.&nbsp; In those with <strong>multiple prior spontaneous abortions</strong>, such as this patient, <strong>antiphospholipid syndrome</strong> (APS) should be suspected.</p><p>APS increases the risk for vascular thrombosis, particularly during pregnancy.&nbsp; Commonly affected vessels are the uteroplacental arteries (ie, spiral arteries), which perfuse the placenta.&nbsp; <strong>Uteroplacental artery thrombosis</strong> in the <strong>first trimester</strong> typically results in <strong>pregnancy loss</strong> because the developing placental trophoblasts are highly sensitive to decreased perfusion.&nbsp; The effects of thrombosis in the <strong>third trimester</strong> are more insidious: Placental perfusion gradually decreases to the point of <strong>uteroplacental insufficiency</strong>, impaired fetal oxygenation/nutrient supply, and <strong>fetal growth restriction</strong> (eg, fundal height 30 cm at 34 weeks).</p><p>Because uteroplacental insufficiency develops gradually, the fetus can initially adapt by redistributing blood flow to vital organs (eg, brain, heart) at the expense of the abdominal viscera, which causes an <strong>asymmetric</strong> or head-sparing pattern of growth restriction (eg, normal head measurement but lagging abdominal circumference).&nbsp; Once the oxygen and nutrient supply decreases below the threshold for maintaining the vital fetal organs, stillbirth occurs.</p><p><strong>(Choice A)</strong>&nbsp; Acute abruptio placentae, premature placental separation from the uterus, is a potential cause of stillbirth.&nbsp; However, patients typically have painful placental bleeding (eg, vaginal bleeding, intrauterine clot on ultrasound).</p><p><strong>(Choice B)</strong>&nbsp; Chromosomal aneuploidies (eg, <a href=\"4023\">trisomy 13</a>, <a href=\"4024\">trisomy 18</a>) are commonly diagnosed in stillborn infants and associated with fetal growth restriction.&nbsp; However, the growth restriction pattern is usually symmetric, and additional fetal anomalies (eg, microcephaly, cardiac defects) are typically present.</p><p><strong>(Choice C)</strong>&nbsp; Intraamniotic infection can lead to stillbirth, but patients typically have fever and leakage of purulent amniotic fluid.</p><p><strong>(Choice D)</strong>&nbsp; <a href=\"1151\">Rh(D) alloimmunization</a> creates maternal anti-D antibodies that can cause stillbirth in Rh(D)-positive infants.&nbsp; Patients with Rh(D)-positive blood types, such as this patient, cannot develop anti-D antibodies (ie, not at risk for alloimmunization).</p><p><strong>Educational objective:</strong><br>Antiphospholipid antibody syndrome (APS) should be suspected in patients with stillbirth and multiple prior pregnancy losses.&nbsp; Stillbirth from APS typically occurs due to uteroplacental artery thrombosis, which leads to uteroplacental insufficiency and asymmetric fetal growth restriction.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23772,
            "topic": "IUFD",
            "titleId": 23772,
            "title": "IUFD",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Abruptio placentae",
                    "choiceNumber": 1,
                    "correctTaken": 268,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chromosomal aneuploidy",
                    "choiceNumber": 2,
                    "correctTaken": 2896,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intraamniotic infection",
                    "choiceNumber": 3,
                    "correctTaken": 1586,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rh(D) alloimmunization",
                    "choiceNumber": 4,
                    "correctTaken": 1310,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uteroplacental artery thrombosis",
                    "choiceNumber": 5,
                    "correctTaken": 10617,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "33481528",
                    "mediaDataId": 0,
                    "title": "Fetal growth restriction: ACOG practice bulletin, number 227.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/33481528",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "33740264",
                    "mediaDataId": 0,
                    "title": "FIGO (international Federation of Gynecology and Obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/33740264",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 109,
            "othersAvgTimeSpent": 81,
            "notes": null,
            "peopleTaken": 16677,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 33,
            "questionId": 2411,
            "questionIndex": 2411,
            "questionText": "<p>A 36-year-old woman comes to the office due to vaginal spotting for the past 4 days.&nbsp; The patient has a history of heavy menstrual bleeding for which she had a progestin-containing intrauterine device placed 3 years ago.&nbsp; She has been amenorrhoeic for the past 2 years but started having vaginal spotting a few days ago and some mild pelvic cramping.&nbsp; The patient has no significant medical history and has never been pregnant.&nbsp; She has no prior sexually transmitted infections.&nbsp; BMI is 30 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 110/70 mm Hg, pulse is 80/min, and respirations are 18/min.&nbsp; Physical examination shows right adnexal tenderness and a closed cervix.&nbsp; Urine pregnancy test is positive.&nbsp; Transabdominal ultrasound shows a small uterus with a thin endometrium and an intrauterine device in place.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32700\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Ectopic pregnancy </strong></p></td></tr><tr><td><p style=\"text-align: center;\"><strong>Risk factors </strong></p></td><td><ul><li>Previous ectopic pregnancy</li><li>Previous pelvic/tubal surgery</li><li>Pelvic inflammatory disease</li></ul></td></tr><tr><td><p style=\"text-align: center;\"><strong>Clinical features </strong></p></td><td><ul><li>Abdominal pain, amenorrhea, vaginal bleeding &nbsp;</li><li>Hypovolemic shock in ruptured ectopic pregnancy</li><li>Cervical motion, adnexal &amp;/or abdominal tenderness &nbsp;</li><li>&plusmn; Palpable adnexal mass &nbsp;</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis </strong></p></td><td><ul><li>Positive hCG</li><li>Transvaginal ultrasound revealing adnexal mass, empty uterus&nbsp;</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management </strong></p></td><td><ul><li>Stable: methotrexate</li><li>Unstable: surgery</li></ul></td></tr></tbody></table></div><p>This patient with <strong>new-onset vaginal spotting</strong>, right adnexal tenderness, and a <strong>positive pregnancy test</strong> likely has an <strong>ectopic pregnancy</strong> (ie, extrauterine pregnancy implantation, most commonly in the <a href=\"4497\">fallopian tube</a>).&nbsp; Although patients with an <strong>intrauterine device</strong> (IUD) have a lower absolute risk for ectopic pregnancy (due to overall lower rates of pregnancy), they are at higher risk for extrauterine implantation if pregnancy occurs.</p><p>This patient&#39;s transabdominal ultrasound shows a thin endometrium and does not reveal a pregnancy (ie, <strong>pregnancy of unknown location</strong>).&nbsp; Pregnancy normally induces endometrial thickening (ie, decidualization) to encourage intrauterine implantation; however, patients with a progestin-containing IUD develop endometrial atrophy (ie, thinning), which can induce amenorrhea but also promote extrauterine implantation.&nbsp; Because an ectopic pregnancy can present with vaginal bleeding, patients with an IUD who develop an abrupt <strong>change in bleeding pattern</strong> and concomitant <strong>adnexal tenderness</strong> require evaluation.</p><p>If transabdominal ultrasonography cannot locate the pregnancy, <strong>transvaginal ultrasonography</strong> is performed because it is more sensitive and can better visualize the adnexa, particularly in obese patients or those with an early gestation.</p><p><strong>(Choice A)</strong>&nbsp; Surgical exploration (eg, diagnostic laparoscopy) is indicated in hemodynamically unstable patients with a suspected ruptured ectopic pregnancy (or in those with contraindications to medical therapy with methotrexate).&nbsp; This patient is hemodynamically stable and should undergo transvaginal ultrasonography to determine pregnancy location.</p><p><strong>(Choice B)</strong>&nbsp; Endometrial biopsies are used to evaluate for endometrial hyperplasia/cancer in nonpregnant women with abnormal uterine bleeding.&nbsp; Although this patient has vaginal bleeding and obesity (a risk factor for endometrial hyperplasia), hyperplasia is unlikely in this patient with a progestin-containing IUD (protective against hyperplasia) and thin endometrium.</p><p><strong>(Choice C)</strong>&nbsp; FSH, TSH, and prolactin levels can be used to evaluate abnormal uterine bleeding.&nbsp; However, this patient&#39;s bleeding is likely pregnancy-related, and these hormone levels would not affect management.</p><p><strong>(Choice D)</strong>&nbsp; IUD removal is recommended for patients with an ultrasound-confirmed intrauterine pregnancy who wish to continue pregnancy; removal decreases the risks of IUD-associated spontaneous abortion, intraamniotic infection, and preterm delivery.&nbsp; This patient&#39;s pregnancy should be located prior to offering IUD removal because an IUD can be left in place with no additional adverse effects if the pregnancy is extrauterine.</p><p><strong>Educational objective:</strong><br>Although patients with an intrauterine device have a lower absolute risk for ectopic pregnancy, they are at higher risk for ectopic implantation should pregnancy occur.&nbsp; Diagnosis is with transvaginal ultrasonography, which has better visualization of pelvic structures compared to transabdominal ultrasonography.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4099,
            "topic": "Ectopic pregnancy",
            "titleId": 4099,
            "title": "Ectopic pregnancy",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Diagnostic laparoscopy",
                    "choiceNumber": 1,
                    "correctTaken": 2046,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial biopsy",
                    "choiceNumber": 2,
                    "correctTaken": 196,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "FSH, TSH, and prolactin levels",
                    "choiceNumber": 3,
                    "correctTaken": 442,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intrauterine device removal",
                    "choiceNumber": 4,
                    "correctTaken": 2989,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transvaginal ultrasound",
                    "choiceNumber": 5,
                    "correctTaken": 11059,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30775665",
                    "mediaDataId": 0,
                    "title": "Ruptured ectopic pregnancy in the presence of an intrauterine device.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30775665",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30737766",
                    "mediaDataId": 0,
                    "title": "Levonorgestrel intrauterine contraceptive systems (13.5 mg and 52 mg) and risk of ectopic pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30737766",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30503132",
                    "mediaDataId": 0,
                    "title": "Demographic, lifestyle, and reproductive risk factors for ectopic pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30503132",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 91,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 16732,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 34,
            "questionId": 3110,
            "questionIndex": 3110,
            "questionText": "<p>A 28-year-old woman, gravida 2 para 1, at 35 weeks gestation comes to the office for evaluation of decreased fetal movement.&nbsp; Over the past 12 hours, the patient has felt only 4 or 5 fetal movements.&nbsp; She rested for an hour and felt only 2 movements, prompting her to come to the office.&nbsp; The patient has had no contractions, vaginal bleeding, or leakage of fluid.&nbsp; She has no chronic medical conditions and has had no complications during this pregnancy.&nbsp; The patient does not use tobacco, alcohol, or illicit drugs.&nbsp; Blood pressure is 136/84 mm Hg and pulse is 84/min.&nbsp; Fetal heart rate is 145/min on Doppler.&nbsp; Fundal height is 35 cm and a slight fetal movement is palpated through the abdominal wall.&nbsp; The remainder of the physical examination is unremarkable.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t46410\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Nonstress test</strong></p></td></tr><tr><td><p><strong>Reactive</strong></p></td><td><ul><li>Baseline of 110-160/min</li><li>Moderate variability (6-25/min)</li><li>&ge;2 accelerations in 20 min, each peaking &ge;15/min above baseline&nbsp;&amp; lasting &ge;15 sec</li></ul></td></tr><tr><td><p><strong>Nonreactive</strong></p></td><td><ul><li>Does not meet criteria for reactivity</li></ul></td></tr></tbody></table></div><p>Initial maternal awareness of fetal movement typically occurs at 16-20 weeks gestation, and maternal monitoring of fetal movement (eg, kick counts) begins in the third trimester (&#8805;28 weeks gestation).&nbsp; Monitoring of fetal movement is a simple method for evaluating fetal activity (eg, tone, limb extension and flexion) because normal fetal activity (eg, &#8805;10 movements in 2 hours) typically indicates a normal fetal acid-base status and low risk of fetal demise.&nbsp; In contrast, <strong>hypoxemic or acidemic fetuses</strong> have reduced fetal activity as a compensatory mechanism to divert blood flow from peripheral tissues to preserve oxygen for the CNS.&nbsp; Therefore, maternal sensation of <strong>decreased fetal movement</strong> requires further evaluation of fetal status <strong>(Choice D)</strong>.&nbsp; The <strong>best next step</strong> in patients with decreased fetal movement is a <strong>nonstress test (NST)</strong>, a noninvasive method of tracking fetal heart rates over time (eg, 20-40 minutes).</p><ul><li><p>Reactive NSTs (eg, &#8805;2 accelerations, baseline 110-160/min, moderate variability) are consistent with a normal fetal acid-base status.</p></li><li><p>Nonreactive NSTs (eg, &lt;2 accelerations) may indicate fetal hypoxemia and acidemia.&nbsp; Additional antepartum testing (eg, biophysical profile) is indicated in these patients.</p></li></ul><p><strong>(Choice A)</strong>&nbsp; An amniotic fluid index is performed in patients with decreased fetal movement if the NST is nonreactive or if fetal decelerations are present to evaluate for oligohydramnios, which may indicate chronic uteroplacental insufficiency and impending fetal compromise.</p><p><strong>(Choice B)</strong>&nbsp; Induction of labor is indicated in patients at &#8805;39 weeks&nbsp;gestation with persistent decreased fetal movement due to the risk of unexplained stillbirth in these patients.&nbsp; It can also be performed at earlier gestation if significant signs of fetal distress (eg, late fetal decelerations) or maternal deterioration are present.</p><p><strong>(Choice E)</strong>&nbsp; Umbilical artery Doppler ultrasound is used to monitor fetal status in pregnancies complicated by maternal hypertension or fetal growth restriction.&nbsp; It is not used in the evaluation of decreased fetal movement.</p><p><strong>Educational objective:</strong><br>The maternal sensation of decreased fetal movement may be due to fetal hypoxemia or acidemia and is concerning for increased risk of demise.&nbsp; Patients with decreased fetal movement require further investigation of fetal status with nonstress testing.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23380,
            "topic": "Antepartum fetal testing",
            "titleId": 23380,
            "title": "Antepartum fetal testing",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amniotic fluid index",
                    "choiceNumber": 1,
                    "correctTaken": 177,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Induction of labor",
                    "choiceNumber": 2,
                    "correctTaken": 33,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nonstress test",
                    "choiceNumber": 3,
                    "correctTaken": 3107,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassurance and routine visit in 1 week",
                    "choiceNumber": 4,
                    "correctTaken": 1433,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Umbilical artery Doppler ultrasound",
                    "choiceNumber": 5,
                    "correctTaken": 231,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27245990",
                    "mediaDataId": 0,
                    "title": "Fetal movement in late pregnancya content analysis of women&#39;s experiences of how their unborn baby moved less or differently.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27245990",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26467769",
                    "mediaDataId": 0,
                    "title": "Fetal movement counting for assessment of fetal wellbeing.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26467769",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24871458",
                    "mediaDataId": 0,
                    "title": "Maternal perception of fetal movement type: the effect of gestational age and maternal factors.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24871458",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 92,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 5054,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 61,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 35,
            "questionId": 13725,
            "questionIndex": 15115,
            "questionText": "<p>A 22-year-old woman, gravida 1 para 0, at 37 weeks gestation comes to labor and delivery for intermittent leakage of fluid for the past 6 hours.&nbsp; The patient has had some intermittent green-tinged fluid and is now having regular, painful contractions every 3-4 minutes.&nbsp; She has had no vaginal bleeding, and fetal movement is normal.&nbsp; The patient has had an uncomplicated pregnancy, and her group B <em>Streptococcus</em> culture was negative a week ago.&nbsp; She has no chronic medical conditions and has had no surgeries.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 90/68 mm Hg, and pulse is 98/min.&nbsp; Fetal heart rate tracing is shown in the <a href=\"21934\">exhibit</a>.&nbsp; Sterile speculum examination confirms rupture of membranes with meconium-stained amniotic fluid.&nbsp; On digital cervical examination, the cervix is 6 cm dilated, 90% effaced, and the fetal vertex is at +1 station.&nbsp; The fetal heart rate pattern is unchanged with maternal repositioning and oxygen administration.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t44513\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Fetal heart rate tracing patterns</strong></p></td></tr><tr><td><p align=\"center\"><strong>Category I</strong></p></td><td><p>Requires all the following criteria:</p><ul><li>Baseline 110-160/min</li><li>Moderate variability (6-25/min)</li><li>No late/variable decelerations</li><li>&plusmn; Early decelerations</li><li>&plusmn; Accelerations</li></ul></td></tr><tr><td><p align=\"center\"><strong>Category II</strong></p></td><td><ul><li>Not category I or III (indeterminate pattern)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Category III</strong></p></td><td><p>&ge;1 of the following characteristics:</p><ul><li>Absent variability + recurrent late decelerations</li><li>Absent variability + recurrent variable decelerations</li><li>Absent variability + bradycardia</li><li>Sinusoidal pattern</li></ul></td></tr></tbody></table></div><p>Intrapartum electronic fetal heart rate (FHR) monitoring is used to assess fetal brain oxygenation status because a well-oxygenated brain provides autonomic control of the heart.&nbsp; FHR patterns are divided into 3 categories based on risk of fetal hypoxia.&nbsp; A category I FHR tracing has a baseline heart rate of 110-160/min with moderate variability (average amplitude 6-25/min) and no decelerations; this pattern has a low risk for fetal hypoxia.&nbsp; Variations from this pattern are suggestive of fetal hypoxia, which can lead to acidemia and possible demise.</p><p>This patient&#39;s <a href=\"21935\">FHR tracing</a> has <strong>absent variability</strong> plus <strong>recurrent late decelerations</strong> (ie, late decelerations with &#8805;50% of contractions)&mdash;diagnostic of a <strong>category III FHR tracing</strong>.&nbsp; Patients with a category III tracing have an <strong>increased risk of severe fetal hypoxia</strong> (and subsequent hypoxic brain injury or demise)&mdash;as seen in this patient with late decelerations, which are likely due to uteroplacental insufficiency.</p><p>The initial management of category III tracings is with maternal repositioning and other <strong>intrauterine resuscitative interventions</strong> (eg, oxygen administration, intravenous fluids, discontinuing uterotonics) that improve uteroplacental blood flow and fetal oxygenation.&nbsp; Patients remote from delivery (not completely [10 cm] dilated) who do not improve with initial resuscitative measures require an immediate <strong>cesarean delivery</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Amnioinfusion is indicated for category III tracings with recurrent <a href=\"14217\">variable decelerations</a> because amnioinfusion may help relieve the umbilical cord compression that causes these decelerations.&nbsp; It is not indicated in the management of recurrent late decelerations.</p><p><strong>(Choice B)</strong>&nbsp; A biophysical profile is not used during the intrapartum period because it does not change management and may delay more appropriate interventions.</p><p><strong>(Choice D)</strong>&nbsp; Oxytocin (a uterotonic agent) augmentation increases the strength and frequency of contractions, thereby worsening uteroplacental blood flow and further compromising fetal oxygenation.&nbsp; Uterotonic agents are discontinued in management of category III tracings.</p><p><strong>(Choice E)</strong>&nbsp; An operative vaginal delivery (eg, vacuum-assisted vaginal delivery) is a management option for patients with category III FHR tracings and complete (10 cm) cervical dilation, not seen in this patient.</p><p><strong>Educational objective:</strong><br>Patients with category III fetal heart rate tracings are at increased risk of fetal hypoxia and subsequent fetal acidemia, hypoxic brain injury, and demise.&nbsp; Initial management is with intrauterine resuscitative interventions; those who do not improve with initial management and are remote from delivery require immediate cesarean delivery.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 22374,
            "topic": "Fetal heart tracing",
            "titleId": 22374,
            "title": "Fetal heart tracing",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amnioinfusion",
                    "choiceNumber": 1,
                    "correctTaken": 1557,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Biophysical profile",
                    "choiceNumber": 2,
                    "correctTaken": 891,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cesarean delivery",
                    "choiceNumber": 3,
                    "correctTaken": 11658,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oxytocin augmentation",
                    "choiceNumber": 4,
                    "correctTaken": 1640,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vacuum-assisted vaginal delivery",
                    "choiceNumber": 5,
                    "correctTaken": 936,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "18757666",
                    "mediaDataId": 0,
                    "title": "The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: update on definitions, interpretation, and research guidelines.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/18757666",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29575562",
                    "mediaDataId": 0,
                    "title": "An evaluation of fetal heart rate characteristics associated with neonatal encephalopathy: a case-control study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29575562",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 60,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 16683,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 70,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 4,
            "name": "CUSTOM"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}